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ABSTRACT 
Modulation of the immune system in the mammalian intestine as an alternate 
explanation for the action of antimicrobial growth promoters 
 
The novel hypothesis that antimicrobial growth promoters (AGP) function by 
modulating the mammalian immune system was tested. Sampling methods to 
characterize the mucosa-associated microbiota of the murine intestine by terminal 
restriction fragment length polymorphism (T-RFLP) analysis indicated that direct plug 
extraction was superior to wash methods. Using T-RFLP analysis, non-therapeutic 
administration of chlortetracycline (CTC) and sulfamethazine to beef cattle did not affect 
the composition of bacterial communities associated with intestinal mucosa and in 
digesta, with exception of those associated with mucosa of the proximal jejunum. 
Similarly, oral administration of non-therapeutic concentrations of CTC did not affect the 
mucosa-associated microbiota of the murine intestine. Oral administration of non-
therapeutic concentrations of CTC prevented weight loss, reduced pathologic changes, 
modulated transcription levels of inflammatory cytokines in C. rodentium-infected mice, 
and did not consistently affect the colonic microbiota. These findings support the 
hypothesis that AGP primarily function by modulating the intestinal immune system. 
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INTRODUCTION 
 
The global human population will reach 7 billion by 2011, and is projected to 
increase to 8.1 billion in 2025 (PRB, 2009). This continuous increase translates to a 
higher demand for high-quality animal products, which resulted in the development of 
techniques to optimize animal production and maintain animal health. In the last decades, 
animal production has been intensified by improvements in husbandry, animal 
reproduction, genetic traits, disease control, and nutrition. Sustainability of animal 
production has been greatly improved with in-feed administration of non-therapeutic 
concentrations of antimicrobial agents (AMA), which are known as antimicrobial growth 
promoters (AGP).  
Unfortunately, administration of AGP has contributed to the emergence of 
antimicrobial resistance (AMR) in zoonotic pathogens (e.g. Inglis et al., 2005), which 
may compromise the therapeutic use of AMA to treat bacterial infections in humans and 
animals. From 1986 to 2006, as a consequence of widespread public health concerns 
regarding AGP use, the European Union gradually banned all AGP, which resulted in 
production losses (Casewell et al., 2003), and several adverse effects for human and 
animal health (Castanon, 2007). It is anticipated that the AGP ban will progressively be 
imposed in other countries. A recent draft guidance issued by the United States Food and 
Drug Administration (FDA) recommended restrictions that would limit the use of AGP to 
assure animal health in North America (FDA, 2010). Therefore, identification and 
development of alternatives to AGP is an urgent issue. However, a lack of knowledge 
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regarding the exact mode of action of AGP has hampered the development and 
application of efficacious substitutes to AGP.  
The difficulty of demonstrating the mode of action of AGP is attributable to the 
complexity and numerous interactions within the mammalian gastrointestinal (GI) tract, 
which harbors more microorganisms than the number of cells in the host (Savage, 1977). 
That germ-free mice do not exhibit enhanced growth as a result of AGP administration 
(Coates et al., 1963) has promulgated the belief that modulation of the intestinal 
microbiota is the primary mode of action of AGP (Dibner and Richards, 2005). However, 
scientific evidence to support the microbiota modulation hypothesis is lacking. 
Many AMA, including those frequently used as AGP, have anti-inflammatory 
properties (Rubin and Tamaoki, 2005). To our knowledge, whether these properties relate 
to the growth promoting action of AGP has not been critically tested. Therefore, the 
overall objective of the current investigations was to further our understanding of the 
mechanisms of action of AGP by testing an alternate hypothesis. Obtaining this 
information is fundamental to the development of efficacious alternatives to AGP. Since 
the current project involved interactions among AGP, the intestinal microbiota, and host 
immune responses, the first study focused on examining the utility of various strategies to 
characterize the mucosa-associated microbiota of the murine intestine, using terminal 
restriction fragment length polymorphism (T-RFLP) analysis. Subsequent studies aimed 
at evaluating the effect of growth promoting concentrations of orally administered 
chlortetracycline (a commonly used AGP in North America) on the intestinal microbiota 
composition of cattle and mice. The final study examined a potential immunomodulatory 
effect of AGP in mice infected with Citrobacter rodentium (an inflammation incitant). 
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CHAPTER ONE 
Literature review 
 
1.1 Non-human use of antimicrobial agents 
The term “antibiotic” was originally defined as: “a chemical substance, produced 
by microorganisms, which has the capacity to inhibit the growth of and even to destroy 
bacteria and other micro-organisms” (Waksman, 1947). Antimicrobial agents comprise 
all drugs that kill or inhibit the growth of microorganisms, such as bacteria, viruses, 
fungi, and protozoa. The use of AMA in food animals, companion animals, aquaculture, 
and horticulture is divided by the World Health Organization (WHO) into four 
categories: therapeutic, prophylactic, metaphylactic, and growth promoting (WHO, 
2003). Therapeutic antimicrobial use is the treatment of established infections. 
Metaphylaxis is a term used for group-medication procedures, intended to treat sick 
animals, while medicating others in the group to prevent disease. Prophylaxis is defined 
as the preventative use of AMA in either individuals or groups to avoid the development 
of infections. Therapeutic, metaphylactic, and prophylactic use of AMA involve 
administration to the animals by various routes (e.g. orally or intramuscularly) at 
therapeutic concentrations for short intervals. An AMA is a growth promoter when 
administered in/on the feed of food animals to promote growth and enhance feed 
efficiency. Growth promoters are usually administered in relatively low concentrations, 
ranging from 2.5 to 125 mg kg-1 (ppm), depending on the drug and animal species 
treated. In many countries, these low concentrations are used for growth promotion as 
well as for prophylaxis, making the distinction between prophylaxis and growth 
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promotion less clear than between prophylaxis and therapy. “Sub-therapeutic” doses of 
AMA are commonly referred to as drug concentrations that are usually lower than 
therapeutic concentrations. Historically, in the United States, the term “sub-therapeutic” 
was defined by FDA as the administration of doses less than or equal to 200 g per ton of 
animal feed for 2 weeks or longer (FDA, 1980). According to the WHO, this term is no 
longer used, since it does not consider animal species or drug potencies (WHO, 2003). 
The term “non-therapeutic” is used as a general term for AMA added in low doses to feed 
or water of healthy animals (Mellon et al., 2001).  
 
1.1.1 Use of antimicrobial agents as growth promoters 
Healthy animals are administered AGP to increase weight gain per unit of feed 
consumed. In other words, AGP are used to improve feed efficiency, making the 
production system more profitable for the producer. Indications of the beneficial effect of 
AGP on host health and nutrition were reported as early as 1946 (Moore et al., 1946). 
The use of AMA as feed additives for farm animals without prescription was first 
approved by the FDA in 1951 (Jones and Ricke, 2003), and since then, the use of AGP in 
livestock has become a common practice around the world. It is noteworthy that 
approximately 90% of the AMA used in agriculture are administered as growth 
promoters and as prophylactic agents, and recommended concentrations for growth 
promotion have increased by 10- to 20-fold since the 1950s (Khachatourians, 1998). 
Quantities of AMA administered annually to Canadian livestock for non-therapeutic 
purposes are largely uncertain, since only a few surveys of AMA treatment practices have 
been conducted (Dunlop et al., 1998; Fraser et al., 2004). However, in the United States, 
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where animal production and treatment practices are somewhat similar to Canada, total 
non-therapeutic AMA administered to cattle, poultry and swine in the late 1990s was 
estimated at 11.1 million kg of AMA, representing eight times more AMA used in animal 
production than in human medicine (Mellon et al., 2001). From these estimates, the 
authors also stated that the use of AMA in livestock increased by approximately 50% 
since 1985, showing that previous assessments of the total non-therapeutic use of AMA 
were greatly underestimated (Mellon et al., 2001). In Canada, many AMA registered as 
AGP are also registered for use in human medicine (Table 1.1).  
 
1.1.1.1 Use of antimicrobial growth promoters in beef 
Typically, beef cattle are raised on pasture, weaned at 7 months of age, shipped to 
backgrounding farms, and eventually to feedlots where they are confined in large groups 
and fed high-energy rations (McEwen and Fedorka-Cray, 2002). Various AMA are used 
in beef production to reduce pneumonia and diarrhea in calves, to control liver abscesses, 
to prevent or treat respiratory outbreaks, and to accelerate growth (McEwen and Fedorka-
Cray, 2002). According to the United States National Animal Health Monitoring System 
(NAHMS), 83.2% of feedlots administered at least one type of AGP to cattle in feed or 
water for prophylaxis or growth promotion in 1999 (NAHMS, 1999). Chlortetracycline 
(CTC) was administered at 51.9%, CTC-sulfamethazine in combination at 16.8%, 
oxytetracycline at 19.3%, and tylosin at 20.3% of feedlots; in addition, tetracyclines were 
fed 4-12 days on average, whereas tylosin was fed 138-145 days, depending on the 
weight of the animal at the arrival at the feedlot (NAHMS, 1999).  
 
 
6 
 
Table 1.1. Antimicrobial agents registered in Canada for use in animals for growth promotion, weight gain and/or feed 
efficiency, and disease prevention, prophylaxis and/or control, along with those registered for human therapy 
 Registered in animal species*  
Antimicrobial agent 
class and drug 
Growth promotion, 
weight gain and/or 
feed efficiency 
Disease prevention, 
prophylaxis, and/or 
control 
Drugs in the same class registered for human 
therapy 
Aminoglycosides    
Neomycin C C, Sw, Ch, T, Sh, H, D, M 
Streptomycin, Neomycin, Gentamicin, 
Amikacin 
Gentamicin  Ch, T  
Spectinomicin  Sw, Br, Brl  
Streptomycin  Pi  
Cephalosporins    
Ceftiofur 
 T 
Ceftriaxone, Cefadroxil, Cefaclor, Cefepime, 
Cefixime, Cefotaxime, Cefotetan, Cefoxitin, 
Cefprozil, Ceftazidime, Ceftriaxone, 
Cefuroxime, Cephalexin, Cephalothin 
Lincosamides    
Lincomycin 
hydrochloride Br Sw, Br, T, Du, G Clindamycin, Lincomycin hydrochloride 
Macrolides    
Erythromycin Br, Brl Sw, Pi, Ch, T, Sh 
Tylosin Sw C, Sw, Ch Erythromycin, Azithromycin 
Nitrofurans    
Nitrofurazone  C, Sw, Ch, Sh, Go, H Nitrofurantoin 
Penicillins    
Penicillin G 
potassium Br, Brl, T T 
Penicillin G 
procaine Sw, Ch, T C, Sw, T, Sh 
Ampicillin, Sulbactam, Cloxacillin sodium, 
Penicillin G benzathine, Penicillin G 
potassium, Piperacillin, Ticarcillin 
Streptogramins    
Virginiamycin  Sw, Brl Quinupristin, dalfopristin 
Tetracyclines    
Chlortetracycline C, Sw, Br, L, T, Sh C, Sw, Ch, T, Sh 
Oxytetracycline C, Sw, Ch, T, Sh C, Sw, T, Ch, Be Tetracycline hydrochloride, Doxycycline 
Pleuromutilins    
Tiamulin  Sw  
Sulfonamides    
Sulfaguanidine  C, Sw, Sh, H  
Sulfamethazine C, Sw C, Sw, Sh, H Sulfamethoxazole 
Ionophores    
Lasolocid sodium C Ch  
Maduramicin  Ch, T  
Monensin C C, Ch, T  
Narasin Sw Ch  
Salinomycin 
sodium C, Sw Ch  
Miscellaneous    
Arsanilic acid Sw, Brl, T   
Bacitracin C, Sw, Ch, T Sw, Br Bacitracin 
Bambermycins Brl, T   
Carbadox Sw Sw  
* C = cattle, Sw = swine, Pi = piglets, Ch = chicken (Br = breeder, Brl = broiler, L = layer), T = turkey,   
Du = duck, G = geese, Sh = sheep, Go = goat, H = horse, D = dog, M = mink, Be = bees. Source: Health 
Canada (HC, 2002)
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1.1.1.2 Use of antimicrobial growth promoters in poultry 
Broilers and turkeys are raised in barns with thousands of birds, and many rations 
contain AMA to prevent coccidiosis, as well as to enhance feed efficiency; nearly all 
medications are administered to entire poultry flocks through feed or water (HC, 2002). 
Bacitracin, one of the most commonly used AMA in starter and grower broiler feeds, is 
used for growth promotion and to control necrotic enteritis caused by Clostridium 
perfringens (McEwen and Fedorka-Cray, 2002). In 2000, AMA were used in starter, 
grower, and final withdrawal feeds by 64.8, 66.9, and 48.1% of broiler production units 
in the United States, respectively (Chapman and Johnson, 2002). 
 
1.1.1.3 Use of antimicrobial growth promoters in swine 
A substantial amount of AMA is used in swine production for prophylaxis and 
growth promotion in North America. In 2006, the NAHMS reported that 43.2, 31.1, and 
25.9% of nursery pig sites administered CTC, carbadox, and tiamulin, respectively, via 
feed (NAHMS, 2006). This report further revealed that 52.6, 44.2, and 29.1% of 
grower/finisher sites administered CTC, tylosin, and bacitracin via feed (NAHMS, 2006). 
A survey made in Ontario revealed that out of 630 operations, 86% added AMA to starter 
(i.e. weanling pig) rations, whereas 29% added AMA to finisher pig rations; the most 
common AMA used were tylosin, carbadox, and furazolidone in weanling pigs, and 
tylosin, lincomycin and tetracycline in finishers (Dunlop et al., 1998). 
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1.1.2 Antimicrobial resistance 
Regardless of the contribution of AMA to animal performance, nutrition and health, 
their use as growth promoters has been increasingly scrutinized due to concerns regarding 
selection for AMR and potential transmission of resistant strains to humans. The misuse 
and overuse of AMA in human medicine, agriculture, and animal production is thought 
by many to be a primary reason for the development of AMR (Conly, 2002), which 
hampers the ability to treat diseases in humans and animals. 
That many food animals are important reservoirs of several human bacterial 
pathogens highlights the importance of AMR. In Canada, the most important human 
pathogens isolated from food animals include Campylobacter jejuni (Rudi et al., 2004), 
Salmonella enterica (Perron et al., 2008), and Escherichia coli (Pruimboom-Brees, 
2000). Bacterial microorganisms with increasing rates of resistance to commonly used 
AMA include methicillin-resistant Staphylococcus aureus (MRSA; Smith et al., 2009), 
vancomycin-resistant enterococci (VRE; Emborg et al., 2003), Shigella spp. (Ahmed et 
al., 2006) and Salmonella spp. (Perron et al., 2008) resistant to multiple AMA, enteric 
Gram-negative bacilli (Klebisiella and Enterobacter species) resistant to extended-
spectrum β-lactams (Emborg et al., 2003; French et al., 1996), penicillin-resistant 
Streptococcus pneumoniae (Goldstein, 1999), Campylobacter spp. and Escherichia coli 
O157:H7 resistant to multiple AMA (Meng et al., 1998; Miflin et al., 2007). The 
emergence of resistance in bacteria that are typically non-pathogenic (e.g. commensal 
bacteria within the GI tract) to humans is also a concern to public health, since these 
bacteria provide a pool of resistance genes that can be transferred to human pathogens 
(HC, 2002).  
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1.1.2.1 Mechanisms of antimicrobial resistance 
There are four main mechanisms of resistance to AMA that evolve in a threatened 
microbial population: (i) acquisition of genes with resistance determinants, such as β-
lactamases that destroy AMA before it can impart an effect; (ii) acquisition of efflux 
pumps that extrude the AMA from the cell; (iii) acquisition of several genes for a 
metabolic pathway which ultimately produces altered bacterial cell walls that no longer 
contain the binding site of the AMA; and (iv) acquisition of mutations that limit access of 
AMA to the intracellular target site, via downregulation of porin genes (Davies, 1994; 
Hughes and Datta, 1983; Tenover, 2006; Wood et al., 1996). Enzymatic inactivation of 
AMA is one of the most common biochemical processes that generate resistance in a 
wide variety of bacteria; genes encoding enzymes that catalyze covalent modifications of 
AMA can undergo mutations that remodel the active site of the enzyme, changing the 
spectrum of antimicrobial substrates that may be modified (Davies, 1994). Acquisition of 
genetic material from other resistant bacteria (i.e. “horizontal evolution”) is accomplished 
through conjugation, transduction, or transformation, and may occur between strains of 
the same species or between different bacterial species or genera (Tenover, 2006). 
Transposons may facilitate the incorporation of multiple resistance genes into the host’s 
genome or plasmids (Tenover, 2006).  
 
1.1.3 Restrictions on the use of antimicrobial growth promoters 
Management options aimed at minimizing adverse human health consequences due 
to AMR have primarily focused on decreasing antimicrobial selection pressure in 
animals. The WHO provided recommendations to reduce the overuse and misuse of 
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AMA in food animals to protect human health, with the overall objective: “To minimize 
the negative impact of the use of antimicrobial agents in food-producing animals whilst 
at the same time providing for their safe and effective use in veterinary medicine” (WHO, 
2000). These recommendations included prohibiting the growth-promoting 
administration of AMA used in human medicine. Subsequent WHO recommendations 
include: (i) to avoid group medication added to animal feed or water whenever possible; 
(ii) to restrict the use of antimicrobials for prescription only; (iii) to ban AGP (WHO, 
2003); and (iv) to implement risk-assessment studies and establish surveillance programs 
to monitor AGP use and AMR in bacteria from food animals (WHO, 2004).  
In 1986, Sweden banned the use of AGP; this was followed by the ban of avoparcin 
and virginiamycin in Denmark between 1995 and 1998. Subsequently, the European 
Union banned the use of avoparcin in 1997, and the four remaining AMA used for 
growth promotion (i.e. bacitracin, spiramycin and tylosin, and virginiamycin ) in 1999, 
on the basis of the “Precautionary Principle” (Casewell et al., 2003). In 2006, the 
European Union instituted a ban on all AMA and hormones used for animal growth 
promotion, and is expected to prohibit the use of anticoccidial substances as feed 
additives before 2013 (Castanon, 2007). This will limit the use of medical substances in 
animal production to veterinary prescription only. In Canada, the recommendations of 
restricted use of AGP from the 2002 Health Canada’s Report of the Advisory Committee 
on Animal Uses of Antimicrobials and Impact on Resistance and Human Health (HC, 
2002) have not been fully implemented, nearly 7 years after publication of the report 
(Holtz, 2009). Many AMA used in human therapy are still used in livestock for growth 
promotion and prophylaxis (Table 1.1), and are listed in the Compendium of Medicating 
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Ingredient Brochures (CMIB); the CMIB lists medicated ingredients permitted in Canada 
to be added to livestock, and specifies directions for use and dosage (CMIB, 2008). 
Oxytetracycline, CTC, and the combination product of CTC/sulfamethazine/penicillin 
deserve special attention, due to their large number of claims at CMIB and their clinical 
importance in human medicine (HC, 2002). 
 
1.1.3.1 Consequences of the restricted use of antimicrobial growth promoters 
Despite the implementation of strategies designed to compensate for the lack of 
AMA usage, the ban of AGP in the European Union has had a profound impact on 
animal and human health (Casewell et al., 2003), although the economic implications of 
the AGP ban are still subject to debate (Graham et al., 2007). The AGP ban in the 
European Union resulted in reduced average weight gain, and increased prevalence of 
diarrhea, enteritis, and mortality in early post-weaning pigs and broilers (Casewell et al., 
2003). Regarding human infections, there was some decrease in vancomycin resistance in 
enterococci isolated from asymptomatic human carriers, but the prevalence of 
enterococci infection did not decrease (Casewell et al., 2003). Despite the lower 
incidence of AMR in some pathogens, resistance level in Salmonella spp. and 
Campylobacter spp. (major zoonotic pathogens in Europe) was not reduced, likely 
because the AMA banned primarily have a Gram-positive spectrum of activity (Casewell 
et al., 2003). Furthermore, an increase in human infection by vancomycin-resistant 
staphylococci was reported and related to a higher usage of vancomycin to treat 
methicillin-resistant staphylococci (Casewell et al., 2003). The increasing rate of health 
problems in livestock due to the AGP ban in Denmark have led to higher therapeutic use 
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of AMA (Figure 1.1). Although the AGP ban in Denmark decreased the occurrence of 
AMR in enterococci isolated from human and animal feces (Aarestrup et al., 2001; 
Casewell et al., 2003), it is not known to what extent the increase of therapeutic use of 
AMA will contribute to the emergence of AMR.  
The economic implications of an AGP ban remain controversial. Based on Swedish 
and Danish experiences, it was estimated that an AGP ban would increase the cost of 
production by $700 million in the United States pork industry over a 10 year period 
(Jensen and Hayes, 2003). Conversely, an economic analysis of the United States poultry 
industry illustrated that the benefits associated with AGP use are not sufficient to 
compensate the costs of the AMA (Graham et al., 2007). This analysis, however, did not 
include veterinary cost changes due to an AGP ban (Graham et al., 2007). 
 
1.2 Morphophysiology of the mammalian gastrointestinal tract 
The lumen of the mammalian GI tract is lined with a thin layer of epithelial cells 
with a large surface area (e.g. over 400 m2 in humans), forming with the complex 
indigenous microbiota, a barrier to protect the host against pathogens (MacDonald and 
Monteleone, 2005). Mucosa, which includes the epithelium and lamina propria (i.e. thin 
layer of connective tissue that underlies the epithelium) collectively, along with 
submucosa, muscularis, and serosa, comprise a series of functional layers of the GI tract 
(Mueller and Macpherson, 2006). As a consequence of constant contact with 
microorganisms, the GI mucosa has evolved multiple layers of protection (Figure 1.2). 
Epithelial cells are joined by tight junctions, which exclude large molecules and 
microorganisms from contact with immune cells in the lamina propria (Kelsall, 2008).  
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Figure 1.1. Total administration of AMA in Denmark from 1996 to 2001 (Metric Tons of 
active ingredients). Source: Iowa Ag Review Online. Adapted from Danish Veterinary 
Institute - DANMAP 2002; Jensen and Hayes, 2003). 
 14
 
Figure 1.2. Tissue organization and structure of the small intestine. Adapted from Tortora 
and Derrickson, (2006). 
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The small intestine consists of proximal, central, and distal areas, designated the 
duodenum, jejunum, and ileum, respectively (Kelsall, 2008). The primary function of the 
small intestine is nutrient absorption (Kelsall, 2008). The initial section of the large 
intestine is the cecum, followed by the colon and rectum. The primary function of the 
large intestine is absorption of water and electrolytes (Turnberg, 1970). Additionally, 
bacteria present in the large intestine may produce biologically active metabolites from 
dietary components (e.g. short-chain fatty acids) which are beneficial to the nutrition and 
health of the host (Davis and Milner, 2009). 
 
1.2.1 Gastrointestinal microbiota 
The human GI microbiota represents a highly diverse and complex community, 
composed of up to 1014 cells (Ley et al., 2006), representing more than 500 distinct 
bacterial species (Eckburg et al., 2005). Two controlling factors have roles in the 
complexity of microbial communities and associated host-functions within the GI tract: 
bacteria-bacteria interactions and bacteria-host interactions. The functional adaptability 
of the GI microbial community and host selection factors for specific bacteria are 
fundamental to the stability of the microbiota, which contributes to the host’s health and 
nutrition (Backhed et al., 2005). Essential attributes that the host has not evolved on its 
own and that are provided by the GI microbiota include: physiological transformations to 
enhance uptake of nutrients, establishment and maintenance of immune homeostasis, 
prevention of diseases, modulating the immune response, and eliminating opportunistic 
pathogens from the GI tract by competitive exclusion (Backhed et al., 2005). The most 
evident physiologic and morphologic differences between germ-free (i.e. “axenic”) and 
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conventional mice are manifested in the GI tract, and include cecal enlargement, and loss 
of connective tissue and small vessels in the lamina propria in germ-free mice (Coates, 
1975). A decrease in blood flow to organs that would normally have a close contact to 
microorganisms (e.g. skin, liver, digestive tract), and reduced cardiac output have also 
been reported in germ-free mice (Coates, 1975; Gordon and Pesti, 1971). Reduced 
cardiac output was attributed to the fact that, in conventional mice, there are stimulatory 
effects of the microorganisms on the chemical energy and oxygen requirements of organs 
they are in contact with. Therefore, the weights of organs that harbour microorganisms in 
conventional animals, as well as heart weight and blood flow, are reduced in germ-free 
mice. The growth of germ-free animals is consistently enhanced, probably due to more 
efficient digestion and absorption of food, attributed to the lack of microorganisms that 
compete for nutrients (Coates, 1975). Conversely, the defense systems of germ-free 
animals are less developed (Coates, 1975). 
 
1.2.1.1 Methods to characterize the gastrointestinal microbiota 
The study of GI microbial ecology involves assessments of abundance and diversity 
of microorganisms, their activity and their relationship with each other and with the 
animal host (Zoetendal et al., 2004). Although the application of anaerobic cultivation 
techniques contributed to the identification of numerous taxa, it was the development of 
molecular-based techniques that expressively expanded our knowledge of bacterial 
community structure and function, and shed light on the richness and complexity of the 
GI microbiota (Weng et al., 2006).  
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The 16S rRNA gene is widely used for phylogenetic studies, since it is universally 
distributed, and includes both conserved regions among various species of bacteria 
(Weisburg et al., 1991), and variable regions that can be taxon specific (Stackebrandt and 
Goebel, 1994). However, sequence analysis of clone libraries containing the near 
complete 16S rRNA gene (i.e.  1500 bp; Sanger sequencing) are impractical for studies 
involving large number of samples containing diverse microbial communities. 
Pyrosequencing methods enable direct sequencing of the target gene (i.e. without 
cloning), and are faster than the Sanger method; however, sequence reads with 
pyrosequencing are currently restricted to 450 bp or less (Ronaghi, 2001). Despite the 
success of sequencing methods to explore microbial diversity and to identify species in 
microbial communities, fingerprinting methods, such as denaturing/thermal gradient gel 
electrophoresis (DGGE/TGGE; Muyzer and Smalla, 1998), and T-RFLP (Liu et al., 
1997) enable the comparative assessment of community diversity and composition, 
which is an important goal in microbial ecology. The T-RFLP technique comprises the 
isolation of total community DNA and amplification of 16S rRNA genes with universal 
or domain-specific primers, at least one of which is fluorescently labelled; this is 
followed by a restriction enzyme digestion and the determination of terminal restriction 
fragments (T-RFs) with the use of automated genetic analyzers (Liu et al., 1997). 
Fingerprinting profiles in T-RFLP analysis largely depend on the restriction enzyme 
used, and HaeIII has been effective in T-RFLP analyses of fungi (Edwards and Turco, 
2005), archaea (Moeseneder et al., 2001), and bacteria (Zhang et al., 2008). The use of 
more restriction digests in independent reactions improves species resolution. However, it 
has not been determined whether the use of multiple enzymes in a single reaction 
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improves species resolution, especially in highly complex communities. Despite the use 
of T-RFLP technique for species identification through the distinctive restriction site 
position in each taxon (i.e. T-RF length), there has been limitations in accurately 
predicting microbial community composition due to: (i) inconsistencies between true T-
RF length and observed T-RF length when using primers labelled with different 
fluorescent dyes (Pandey et al., 2007), (ii) shared T-RFs across species, and (iii) multiple 
T-RFs within the same species (Dickie and FitzJohn, 2007). Nevertheless, T-RFLP has 
been considered reliable for comparative microbial community analysis (Hartmann and 
Widmer, 2008). It has been reported that similar fingerprint profiles of bacterial diversity 
in soils were obtained by DGGE and T-RFLP techniques (Smalla et al., 2007). 
Conversely, assessment of bacterial diversity in a marine environment revealed that more 
phylogenetic groups were observed using T-RFLP and clone library analysis than using 
DGGE, which usually produced fewer operational taxonomic units (Zhang et al., 2008). 
One of the limitations of PCR-based technologies is potential PCR bias, which may 
substantially affect genetic profiles and analyses. Artifacts generated in PCR reactions 
can originate from chimeric sequences, nucleotide misincorporation, heteroduplexes (Qiu 
et al., 2001), partially single-stranded DNA (Egert and Friedrich, 2005), residual activity 
of DNA polymerases (Hartmann et al., 2007), and differential copy number of the target 
gene among taxa (Klappenbach et al., 2001). Nevertheless, advancements in limiting 
PCR-related bias (i.e. treatment of partially single-stranded amplicons with Klenow 
fragment; Egert and Friedrich, 2005), and in statistical analyses of genetic profiles (Abdo 
et al., 2006; Culman et al., 2008) have resulted in more reliable and accurate 
characterization of microbial communities. 
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1.2.2 Mucosal immunity 
The mammalian GI tract is one of the largest immunological organs of the body, 
containing more lymphocytes and plasma cells than the spleen, bone marrow, and lymph 
nodes combined (Stokes and Bailey, 2000). The gut-associated lymphoid tissue (GALT) 
contains cells organized within the lymphoid follicles of the Peyer’s patches, as well as 
those distributed throughout the lamina propria and intestinal epithelium (Stokes and 
Bailey, 2000). The mucus layers overlying the intestinal epithelium are fundamental for 
the structure and functional stability of the microbiota, which facilitates nutrient 
exchange and induces host innate immunity (Sonnenburg et al., 2004), and are variable in 
thickness along the GI tract (Figure 1.3). The inner mucus layer (i.e. firmly adherent 
layer) of the murine colon is formed by a dense concentration of mucins, which serve as a 
functional physical barrier to reduce the direct contact of resident bacteria with the 
underlining intestinal epithelium (Johansson et al., 2008). Conversely, there are 
substantial amounts of bacteria present in the outer loose mucus layer of the murine 
colon, which seems to provide an ideal environment for resident microbial communities 
(i.e. mucosa-associated; Johansson et al., 2008). It is now recognized that mucosa-
associated microbial communities differ from those present in digesta or feces (Eckburg 
et al., 2005; Zoetendal et al., 2002).   
 
1.2.2.1 Innate and adaptive immunity 
The mucus and epithelial barriers do not completely prevent luminal antigens from 
entering underlying intestinal tissues. Innate mechanisms of defense, which occur 
naturally as a result of the genetic constitution and microbial environment within the GI  
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Figure 1.3. A schematic showing the thickness of the firmly adherent and loosely 
adherent mucus layer throughout the GI tract of rats. In the stomach and colon, the firmly 
adherent layer was continuous, but in the small intestine it had a "patchy" distribution and 
was absent on individual villi. The loosely adherent mucus layer was removable by 
careful suction, whereas the firmly adherent mucus layer was not. Values on the x-axis 
represent mean (standard errors) thickness values at each location. Figure recreated from 
Atuma et al. (2001). 
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tract, regulate intestinal homeostasis and contribute to the control of inflammatory 
reactions in the lamina propria (Moal and Servin, 2006). As indicated above, the surface 
of intestinal epithelial cells is covered by a well-developed layer of membrane-bound 
glycoproteins and mucus that effectively prevent bacterial attachment (Kelsall, 2008). 
Intestinal epithelial cells modulate mucosal and adaptive immune responses by secreting 
products that activate or inhibit immune cells (Rumbo and Schiffrin, 2005). Inflammation 
is a biological response of tissues to harmful stimuli, such as pathogens, damaged cells or 
irritants, protecting the host by removing the injurious stimuli and initiating the healing 
process for the tissue (Kelsall, 2008). Both innate and adaptive (acquired) immune 
responses are involved in clearing bacteria from the lamina propria. 
Synthesis of antimicrobial peptides, pro-inflammatory cytokines, chemokines, and 
secondary anti-inflammatory responses, are part of innate immune responses (Thoma-
Uszynski et al., 2001). Adaptive immune responses, which are long-lasting and specific 
cellular responses to antigens, contribute to innate responses by limiting exposure of the 
mucosal immune system to commensal bacteria (Kelsall, 2008). Adaptive immune 
responses are divided into humoral immunity, which comprise antibodies, secreted by B 
lymphocytes and circulating in the blood, and cell-mediated immunity, which comprise T 
lymphocytes that are able to either directly destroy infected cells or activate phagocytes 
to kill pathogens (Dempsey et al., 2003). An effective overall immune response depends 
on the interplay and regulation between the innate and adaptive immune systems. It is 
accepted that innate immune signals play a critical role in initiating and instructing the 
development of adaptive effector mechanisms, despite the independent evolution of these 
two classes of immunity (Dempsey et al., 2003). The intersection between innate and 
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adaptive responses is intricate and finely balanced, and depends on the accurate and 
effective translation of the innate signals of infection or damage. 
 
1.2.2.2 Host-pathogen interaction 
Microorganisms can be recognized by intestinal epithelial cells when they penetrate 
mucins and resist host’s antimicrobial peptides. Innate immunity is initiated by germ-line 
encoded pattern recognition receptors (PRRs) that recognize conserved molecular 
patterns (i.e. pathogen-associated molecular patterns, PAMPs) of microorganisms 
(Uematsu and Akira, 2006). Toll-like receptors (TLR) and nucleotide-binding 
oligomerisation domain isoforms (NOD)-like receptors are PRRs that detect a wide range 
of microorganisms that may be associated with mucosal surfaces (e.g. bacteria, fungi, 
protozoa, and viruses; Uematsu and Akira, 2006). Recognition of PAMPs by PRRs 
triggers the activation of signal transduction pathways, which induce dendritic cell 
maturation and cytokine production, resulting in an adaptive immune response that can 
eliminate pathogens and shape the intestinal microbiota (Akira et al., 2006; Kelly et al., 
2005). 
 
1.2.2.3 Acute-phase response 
When an immune response is triggered by a microorganism, several pro-
inflammatory cytokines, such as interleukin (IL)-1, IL-6, and tumor necrosis factor 
(TNF)-α are released by macrophages and monocytes, mediating a systemic stress 
response known as the acute-phase response (Klasing and Korver, 1997). Cytokines are 
polypeptidic factors produced by a wide variety of cells, including leukocytes (e.g. 
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monocytes and lymphocytes); some can be considered mediators of immune-neuro-
endocrine interactions, modulating the length, intensity, and type of immune response 
(Besedovsky and del Rey, 1996). A reciprocal expression of receptors for products of the 
nervous, endocrine, and immune systems, and the extensive neural supply to immune 
tissues, such as the spleen and lymph nodes, constitutes the basis of immune-neuro-
endocrine interactions (Besedovsky and del Rey, 1996). Innate immune responses at 
systemic and localized levels are generally inhibited by the neuro-endocrine stress 
response and the sympathetic and parasympathetic nervous system, whereas local innate 
immune responses tend to be enhanced by the peripheral immune system (Sternberg, 
2006).  
The hypothalamic-pituitary-adrenal (HPA) axis provides a physiological feedback 
loop on inflammation (Sternberg, 2006). In response to antigenic stimuli, cells from the 
paraventricular nucleus of the hypothalamus produce corticotrophin-releasing hormone, 
which stimulates leukocytes (Weigent and Blalock, 1995) and the pituitary gland to 
release adrenocorticotropic hormone (ACTH) into the blood; substantial amounts of 
corticosterone are released from the adrenal glands, inhibiting protein synthesis of 
skeletal muscles. Cytokines can systemically limit growth by direct action on tissues, or 
indirectly through their effects on the endocrine (Klasing and Korver, 1997) and nervous 
systems (Sternberg, 2006). They induce several metabolic, cellular and behavioral 
alterations, such as anorexia, increased basal metabolic rate (BMR), and protein turnover, 
contributing to the development of fever and to an increase in the rate of feed conversion 
(i.e. feed mass necessary to be converted to 1 kg of body mass) and degradation of 
skeletal muscle protein (Klasing and Korver, 1997). The amino acids made available due 
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to decreased rates of muscle accretion are subsequently utilized by the liver for the 
synthesis of acute-phase proteins, which enhance innate immunity and modulate cytokine 
activity (Klasing and Korver, 1997). Hepatic glycogenolysis is induced by IL-1, and the 
glucose released is used by muscles, representing a shift away from fatty acids and 
toward carbohydrates as a primary energy substrate by some tissues (Sakurai et al., 
1994). The changes in metabolism following an inflammatory response by the immune 
system (Figure 1.4) have been referred to as “immunologic stress” (Klasing et al., 1987). 
Immunologic stress is defined as a response that modifies the partitioning of dietary 
nutrients away from growth and skeletal muscle accretion, and towards metabolic 
processes that support the immune response and disease resistance (Roura et al., 1992). 
Hepatic acute-phase response is an anabolic process that increases nutrient use by the 
immune system (e.g. up to 6-fold in case of lysine uptake; Klasing, 2007).  
 
1.2.2.4 Regulation of the T-cell response 
Dendritic cells belong to a heterogeneous population of cells present in an 
immature state within the GI mucosa and skin, and along with macrophages, play a 
critical role in communicating innate signals of infection or damage to the adaptive 
immune system (Dempsey et al., 2003). Central to T-cell activation, is the recognition of 
antigens in the peptide-binding groove of major histocompatibility complex (MHC) 
molecules, which are expressed by antigen-presenting cells, such as macrophages and 
dendritic cells (Vyas et al., 2008). Maturation signals obtained from the activation of the 
innate immune system produce varied profiles of cytokines and costimulatory receptors, 
and determine the type of adaptive immune response mounted by the host. 
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Figure 1.4. Schematic representation of an acute-phase response following stimulation of 
the immune system. Cytokines IL-1, IL-6, and TNF-α orchestrate this response by direct 
actions on tissues (bold arrows) and by indirect actions (dashed arrows) through the 
endocrine system, resulting in metabolic, behavioral and cellular modifications that limit 
growth and skeletal muscle deposition. Adapted from Klasing and Korver (1997), and 
Niewold (2007). 
 26
T-helper (Th)1 cells produce predominantly IFN-γ, IL-2, and TNF-α, and facilitate 
cell-mediated immunity, phagocyte-dependent inflammation, and favor production of 
immunoglobulin (Ig)G1 and IgG3 opsonizing and complement-fixing antibodies 
(Dempsey et al., 2003). Th2 cells produce IL-4, induce IgE production by B cells, evoke 
strong antibody responses, induce eosinophil accumulation, and inhibit several functions 
of phagocytic cells (i.e. phagocyte-independent inflammation; Dempsey et al., 2003; 
Romagnani, 2000). It has been shown that Th1 and Th2 are mutually regulated. For 
instance, IL-12, IFN-γ and IFN-α favor the development of Th1 cells, but inhibit 
development of Th2 cells, whereas IL-4 favor development of Th2 cells, but inhibit 
development of Th1 cells (Parronchi et al., 1992). T-regulatory (Treg) cells regulate both 
Th1 and Th2 responses, and include Th3 cells that exert their suppressive activity by the 
production of TGF-β (Weiner, 2001). In addition, type 1 Treg cells (Tr1) are induced in 
the presence of IL-10 and exert their suppressive activity by producing IL-10 and TGF-β 
(Roncarolo et al., 2001). 
More recently, a distinct subset of effector Th cells, named Th17 cells, was 
described, and are thought to be involved in enhancing antimicrobial host protection 
against mucosal and epithelial extracellular bacteria and some fungi in support of Th1- 
and Th2-mediated immunity (Weaver et al., 2007). Furthermore, Th17 cells have been 
shown to be involved in the pathogenesis of some inflammatory and auto-immune 
disorders (van de Veerdonk et al., 2009). Th17 cells are thought to originate by the 
combined activity of IL-6 and TGF-β, and by the induction of IL-23 produced by 
dendritic cells (Romagnani, 2006). The cytokines produced by Th17 cells, such as IL-
17A and IL-22, evoke inflammation by stimulating fibroblasts, endothelial cells, 
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epithelial cells, and macrophages to produce chemokines, as well as granulocyte colony-
stimulating factor (CSF) and granulocyte-macrophage CSF, which induces the 
recruitment of polymorphonuclear leucocytes (Ye et al., 2001). Whereas IL-4 and IFN-γ 
inhibit Th17 responses, it is not clear if Th17 cells exert inhibitory effects on 
development of Th1 and Th2 cells, and the precise effects of Treg cells on Th17 cells are 
yet unknown (Dempsey et al., 2003).  
 
1.2.2.5 Commensal microbiota and immunity 
Microbial communities associated with mucosal surfaces are thought to be 
remarkably stable throughout the GI tract (Savage, 1987). The stability of the intestinal 
microbiota is probably required to maintain host homeostasis (Schiffrin and Blum, 2002). 
Nevertheless, the GI microbiota can be constantly shaped by both host (e.g. secretory 
substances and peristalsis) and environmental factors (e.g. dietary components, drugs, 
food structure, and ingestion of microorganisms; Egert et al., 2006), which can 
profoundly affect host health. A disruption in the ecological balance of the GI microbiota 
may be detrimental to the host, since the microbiota is thought to provide protection 
against colonization by pathogenic microorganisms (i.e. colonization resistance; Vollaard 
and Clasener, 1994). 
The close and intermittent contact of the GI mucosa with the microbiota results in a 
constant state of “controlled” physiological inflammation (Biancone et al., 2002; Ma et 
al., 2003). Despite the crucial role in maintaining a protective and readily-generated local 
immune response, the controlled inflammation in the mucosa of the GI tract is also 
associated with a catabolic cost to the host (Klasing and Korver, 1997).  
 28
Immunoregulatory molecules released by activated immunocytes in the GI tract ensure 
maintenance of an adequate balance between luminal antigens, including resident 
microorganisms, and the host immune response (Biancone et al., 2002). The “normal” 
indigenous microbiota does not typically exert a strong intestinal epithelial response, but 
may contribute to host-immune modulation (Schiffrin and Blum, 2002). Pathogen 
recognition by immune cells is well known; however, the effect of TLR and NOD on the 
recognition of commensal microbiota is relatively unexplored (Kelly et al., 2005). It is 
well established, however, that resident microorganisms do interact with antigen-
presenting cells (e.g. dendritic cells) in the lamina propria and/or actually cross the 
intestinal epithelial barrier, without causing inflammation (Strober, 2006). Local 
tolerance to commensal microbiota is achieved by the active suppression of T-cell 
response by Treg cells (Kelly et al., 2005).  
 
1.3 Animal models 
Animal models are used in experimental medicine to unravel mechanisms of 
pathogenesis, and to facilitate development of therapeutic and prophylactic methods to 
mitigate or eradicate disease in humans and animals. The complexity of mammalian 
biological systems, combined with the ethical limitation of conducting scientific 
experiments in humans, have necessitated the development of suitable animal models to 
study host-pathogen interactions. Rodents have many advantages as animal models, 
including ease of rearing and tractability, they possess a short life span, there are many 
defined genotypes available, and their microbiota can be readily eliminated or defined. 
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1.3.1 Enteric inflammation models 
In the mammalian GI tract, the association among the microbiota, epithelial cells, 
and mucosal immune cells is essential for the health of the host; it is not possible to study 
such a complex and dynamic interaction in vitro. Many animal models have utilized 
induced mutations or genetic alterations that modify components of the GI tract (i.e. 
microbiota, mucosal immune cells, and/or epithelial cells), with the goal of elucidating 
factors that contribute to disease (Lorenz et al., 2005).  
 
1.3.1.1 Gnotobiotic animals 
The absolute complexity, richness, and potential variation of microbial 
communities within the GI tract have greatly hampered our understanding of the host-
microbiota interaction. To circumvent this difficulty, and to achieve more effective 
assessments of host and microbial relationships, gnotobiotic animals were introduced. 
Gnotobiotic animals are derived by aseptic caesarean section, and are continuously 
maintained with “germ-free” techniques. In gnotobiotic animals, the microbiota is fully 
defined, and can be classified as follows: (i) germ-free or axenic animals, in which the 
gnotobiotes are devoid of microorganisms; and (ii) defined flora animals, in which the 
gnotobiotes are maintained under isolator conditions in association with one or more 
known types of microorganisms (Gordon and Pesti, 1971). Gnotobiotic animals may be 
used to study external or endogenous factors (i.e. nutrition, immune reactions, responses 
to various forms of injury), where the unconfounded actions of such factors, affected or 
unaffected by associates in the host, are of interest (Gordon and Pesti, 1971). Germ-free 
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mice have been essential in investigating intrinsic mechanisms of disease, such as the 
susceptibility of mice to C. rodentium (Itoh et al., 1988).  
Due to the high susceptibility of germ-free mice to microorganisms, enteric 
infections were a common occurrence in early research with gnotobiotic animals (Gordon 
and Pesti, 1971). This susceptibility can be attributed to the lack of colonization 
resistance in germ-free animals (van der Waaij et al., 1971). The introduction of a 
defined-flora to germ-free mice was found to confer colonization resistance (Gordon and 
Pesti, 1971). The most complex defined-flora model to date is the Altered Schaedler 
Flora (ASF), which is produced by the colonization of germ-free rodents with four 
members of the original Schaedler Flora (i.e. the two lactobacilli, Bacteroides distasonis, 
and an extremely oxygen sensitive fusiform bacterium), a spiral-shaped bacterium 
(Flexistipes sp.), and three new fusiform extremely oxygen-sensitive bacteria 
(Clostridium spp., and Eubacterium plexicaudatum; Sarma-Rupavtarm et al., 2004). The 
ASF model is an important tool to assess host responses to pathogens and to the intestinal 
microbiota, in a defined and controlled environment. For instance, the use of gnotobiotic 
mice colonized with ASF have revealed that microbial perturbation with Helicobacter 
billis or Brachyspira hyodysenteriae induced differential immune responses to non-
pathogenic resident bacteria, which exacerbates intestinal inflammation (Jergens et al., 
2006).  
 
1.3.1.2 Citrobacter rodentium model 
Citrobacter rodentium (i.e. formerly C. freundii biotype 4280 and Citrobacter 
genomospecies 9; Luperchio et al., 2000), is a gram negative bacterial pathogen that 
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causes transmissible murine colonic hyperplasia (TMCH) in immunocompetent 
laboratory mice (Barthold et al., 1978; Mundy et al., 2005). C. rodentium is considered a 
rodent equivalent of Escherichia coli infection in humans (Schauer et al., 1995), and 
elicits a host response similar to that found in murine models of inflammatory bowel 
disease (Higgins et al., 1999). Age, host, genetic background, diet, and the indigenous 
microbiota have all been shown to influence colitis incited by C. rodentium (Barthold et 
al., 1977; Luperchio and Schauer, 2001), and mice that recover from TMCH may be 
refractory to reinfection (Barthold et al., 1978). Infection in adult mice is subclinical and 
self-limiting, whereas suckling mice exhibit severe colitis with necrosis and mucosal 
erosions, as well as visible clinical signs (Luperchio et al., 2000). The degree of mucosal 
hyperplasia caused by C. rodentium is severe in NIH Swiss mice and moderate in 
C3H/HeJ mice, whereas C57BL/6J and DBA/2J mice exhibit the least degree of mucosal 
hyperplasia (Barthold et al., 1977). 
C. rodentium infection in laboratory mice has proven to be a robust model to assess 
mechanisms of pathogen-induced host responses (Borenshtein et al., 2008), since it 
causes attaching/effacing lesions in the intestinal epithelium, which lead to strong host 
responses (Skinn et al., 2006). C. rodentium colonizes the apical surface of the large 
intestinal mucosa, causing mucosal hyperplasia with limited inflammation and epithelial 
cell hyperproliferation in the descending colon, characterized by crypt elongation, 
increased mitotic activity, mucosal thickening, variable mucosal inflammation, crypt 
abscesses, occasional erosions and ulcers, and goblet cell depletion (Barthold et al., 
1978). Infection with C. rodentium generates a predominantly lymphocytic infiltrate, 
characterized by CD4+ T cells situated near the proliferative epithelial crypts, and up-
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regulation of Th1-related cytokines (i.e. IL-12, IFN-γ, and TNF-α; Higgins et al., 1999; 
Spahn et al., 2008), and Th17-related cytokines (IL-22, IL-17, and IL-6; Symonds et al., 
2009; Zheng et al., 2008), which are critical for resolution of infection. T and/or B 
lymphocytes mediate most of the pathology and inflammation in the later stages of 
infection by C. rodentium and are required for clearance of the bacterium (Vallance, 
2002). Bacteremia and extra-intestinal infection are not hallmarks of TMCH, though 
recovery of bacteria from blood, liver, and spleen has been reported (Luperchio and 
Schauer, 2001).  
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CHAPTER TWO 
Hypotheses and objectives 
 
2.1 Microbiota modulation hypothesis 
Suppression of the intestinal microbiota is frequently regarded as the main 
mechanism of action of AGP (Dibner and Richards, 2005). In this regard, studies of 
mechanisms of growth promotion by AGP have focused almost exclusively on 
interactions between the microbiota and AMA. With respect to livestock production, 
AGP are frequently thought to modulate microbial communities, which provides 
maximum benefits with minimum costs to the host (Dibner and Richards, 2005). That 
AGP do not exert beneficial effects on the growth performance of germ-free mice, 
combined with the observation that AGP-fed animals have a thinner intestinal wall, have 
sustained this belief (Niewold, 2007). In this regard, several mechanisms to explain the 
contribution of AGP to animal health and growth are prominent in the literature: (i) AGP 
decreases opportunistic pathogens, therefore limiting subclinical infections and reducing 
the metabolic costs for the host; (ii) AGP reduce microbial production of growth-
depressing metabolites (e.g. short-chain fatty acids from microbial fermentation); (iii) 
AGP reduce microbial use of nutrients; and (iv) AGP enhance host uptake of nutrients 
(i.e. digestibility), due to a thinner intestinal wall (Dibner and Richards, 2005; Niewold, 
2007). 
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2.2 Alternative hypotheses 
Scientific evidence supporting the microbiota modulation hypothesis of AGP action 
is lacking, and Niewold (2007) recently emphasized several reasons why the intestinal 
microbiota is an unlikely target for the action of AGP: (i) the AMA dose used for growth 
promotion is normally lower than the minimum inhibitory concentration (MIC) for 
enteric pathogens and other bacteria; (ii) AMA promote a similar growth effect in various 
production animals, despite considerable differences in their intestinal bacterial 
communities; (iii) major shifts occur in the composition of the intestinal microbiota as an 
animal develops; (iv) there are no available data on whether AGP actually enlarges the 
total mucosal surface by thinning the intestinal wall; (v) the use of various AMA, which 
have varying spectra of action, can promote similar growth promotion in animals; (vi) not 
all AMA have growth-promoting properties, whereas all of them should affect the 
microbiota according to the original hypothesis; (vii) management strategies using 
alternatives to AGP, including agents known to affect the intestinal microbiota, have 
highly variable and unexpected effects when compared to AGP (Utiyama, 2004); (viii) 
Lactobacillus spp. and Enterococcus spp. are probiotic bacteria used for promoting 
growth in livestock, but bacteria in both genera appear to produce growth-depressing 
metabolites; and (ix) it is unlikely that the composition of the microbiota can be 
manipulated towards a desired community composition, considering the complexity of 
the intestinal ecosystem (Savage, 1977). Furthermore, recent findings indicate the AMR 
to AMA is prevalent amongst the intestinal microbiota of livestock. For example, the 
fecal community of intensively raised swine continuously fed AGP contained a high level 
of erythromycin methylase genes conferring resistance to macrolide-lincosamide-
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streptogramin B AMA (Kalmokoff et al., 2010). This further challenges the microbiota 
modulation hypothesis. Hence, other mechanisms of AGP action, including an alternative 
target, should be considered to explain the consistent effects of AGP in such a complex 
environment.  
It has been suggested that AGP may directly regulate tissue deposition via an 
endocrine involvement. Rumsey et al. (1999) suggested that an effect of CTC on the 
pituitary gland of ruminants might be the route by which AGP improve energy efficiency 
in tissue deposition, but not necessarily in muscle deposition.  
Niewold (2007) proposed an interaction with host factors to explain the consistency 
of AGP activity. He suggested that AGP would decrease “physiologic” and constant 
inflammation of the intestinal mucosa, which would enhance nutrient utilization for 
growth purposes by decreasing the catabolic costs of mounting an immune response. An 
immunomodulatory effect of AGP would limit a cascade of immunological events (i.e. 
acute-phase response to antigenic stimuli) that demands great metabolic expenditure from 
the host. It has been reported that the growth promotion effect of AGP was enhanced in 
broiler chicken that were maintained in an unsanitary environment, by decreasing 
immunologic stress (Roura et al., 1992). These authors, however, did not attribute the 
decrease in circulating IL-1 (i.e. cytokine involved in the stress response) to a direct 
effect of AGP on the host immune system (Roura et al., 1992). Some AMA (e.g. 
macrolides, tetracyclines and sulfonamides) have immunomodulatory properties; they 
can down-regulate prolonged inflammation, increase mucus clearance, stimulate or 
impair activation of the host immune system, and modify phagocyte activity by altering 
their functions, including chemotaxis, phagocytosis, oxidative burst, bacterial killing, and 
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cytokine production (Rubin and Tamaoki, 2005). Furthermore, therapeutic concentrations 
of CTC modulated acute response in ex vivo perfused pig livers, and decreased the 
secretion of TNF-α by cultured Kupffer cells (Akunda et al., 2001).  
 
2.3 Research hypotheses and objectives 
I hypothesize that AGP do not exert a substantial effect on the composition of the 
intestinal microbiota of mammalian livestock, and that AGP function by modulating 
intestinal immune responses. This is referred to as “immunomodulation hypothesis” 
hereafter (Figure 2.1). To test the immunomodulation hypothesis, the following research 
objectives were formulated: 
1) Test the efficiency of various sampling methods to characterize mucosa-
associated bacterial communities (Chapter 3); 
2) Assess the utility of Klenow fragment and mung bean nuclease, which are 
deemed to reduce T-RFLP bias, on the characterization of microbial communities 
(Chapter 3); 
3) Evaluate the effect of orally administered non-therapeutic doses of CTC and 
sulfamethazine (i.e. AS700; model AGP for beef cattle) on the composition of bacterial 
communities associated with the intestinal mucosa and digesta of cattle (Chapter 4); 
4) Establish a murine AGP model, and evaluate the effect of orally administered 
non-therapeutic doses of CTC on the composition of bacterial communities associated 
with the intestinal mucosa of mice (Chapter 4); 
5) Using the murine AGP model, assess the modulatory effects of orally 
administered non-therapeutic doses of CTC on inflammatory cytokine transcription 
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Figure 2.1. Schematic representation of the interactions involved in this project. The dark 
arrow represents the immunomodulation hypothesis for the growth promoting action of 
AGP. 
AGP
Citrobacter 
rodentium Microbiota
Mucosal 
immunity 
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levels, pathologic changes, and weight loss associated with C. rodentium infection, as 
well as on the composition of microbiota of the murine colon (Chapter 5). 
I contend that the development of alternatives to AGP will only be effectively 
accomplished once the appropriate target for their growth promoting action is identified. 
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CHAPTER THREE 
Characterization of mucosa-associated bacterial communities of the murine 
intestine by terminal restriction fragment length polymorphism1 
 
ABSTRACT 
Terminal restriction fragment length polymorphism is a molecular technique used 
for comparative analysis of microbial community composition and dynamics. Three 
sampling methods for recovering bacterial community DNA associated with intestinal 
mucosa of mice were evaluated: mechanical agitation with PBS, hand washing with PBS 
containing Tween 80, and direct DNA extraction from mucosal plugs. In addition, the 
utility of two methods (i.e. Klenow fragment and mung bean nuclease) to reduce single-
stranded DNA artifacts was tested. Based on T-RFLP analysis, there were diverse 
communities of bacteria associated with mucosa of the murine ileum, cecum, and 
descending colon. Although there was no significant difference in bacterial community 
composition between the mechanical agitation and direct DNA extraction methods 
regardless of intestinal location, community diversity was reduced for the wash method 
in the colon. The use of Klenow fragment and mung bean nuclease has been reported to 
eliminate single-stranded DNA artifacts (i.e. pseudo-T-restriction fragments); however, 
neither method was beneficial for characterizing mucosa-associated bacterial 
communities of the murine cecum. In conclusion, mechanical agitation and direct plug 
extraction yielded equivalent bacterial community DNA from the mucosa of the small 
                                                 
1 Chapter published as: Costa, E., Puhl, N. J., Selinger, L. B. and Inglis, G. D. (2009). Characterization of 
mucosa-associated bacterial communities of the mouse intestine by terminal restriction fragment length 
polymorphism: Utility of sampling strategies and methods to reduce single-stranded DNA artifacts. Journal 
of Microbiological Methods, 78(2): 175-180. 
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and large intestine of mice, but the latter method was superior for logistical reasons. In 
addition, statistical detection of T-RFs, analysis of variance for T-RF number, and group 
significance test through statistical randomization were used to ensure more reliable and 
comprehensive analysis of T-RFLP data. 
 
3.1 INTRODUCTION 
The ultimate goal of modern microbial ecology is not only to identify particular 
species within bacterial communities, but also to explore community structure and 
dynamics in complex natural environments. Molecular approaches, such as PCR-based 
methods coupled with rRNA gene-based phylogeny, enable the identification of 
uncultured organisms, contributing to the characterization of diverse bacterial 
communities (Weng et al., 2006). Sequence analysis of 16S rRNA gene libraries for 
species determination can be laborious and time consuming, becoming impractical for 
substantive studies of microbial diversity and function in highly complex communities. 
Rapid and more comprehensive quantitative assessment of bacterial communities is 
possible using T-RFLP analysis, a molecular technique based on restriction site 
polymorphisms of the 16S rRNA gene (Liu et al., 1997). Despite being often reduced to 
the level of species (i.e. unique restriction site position to differentiate species), T-RFLP 
analysis is also used for temporal and spatial comparative analyses of microbial 
community composition (Clement et al., 1998). 
Assessments of intestinal microbial communities are challenging, as luminal 
bacteria (e.g. bacteria released from mucosal surfaces into ingesta) are transient, and may 
not necessarily represent microbial communities of a particular location of the intestine 
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(Savage, 1977). Mucosa-associated bacteria are likely to best represent intestinal 
communities, as they are uniformly distributed, differ from fecal communities, and are 
influenced by host factors (Zoetendal et al., 2002). Effective recovery of DNA from 
samples is essential for DNA-based community analyses (Apajalahti et al., 1998). The 
sampling process and DNA extraction may result in random bias (Frostegard et al., 
1999), which could increase with the extraction of DNA from the whole intestinal tissue, 
due to a higher chance of insufficient or preferential disruption of bacterial cells 
(Ingrassia et al., 2001). The release of bacteria from mucosal surfaces by hand washing 
with buffer containing a surfactant has been used (Gong et al., 2002; Li et al., 2003), as 
has agitation of tissues in buffer using a bead-beater (Sait et al., 2003). Nevertheless, the 
efficacy of these methods for recovering bacteria from the surface of mucosa has not 
been adequately investigated (Li et al., 2003), and it is not known if these strategies will 
affect random sampling bias.  
Another potential drawback of the T-RFLP technique is PCR-related bias (Egert 
and Friedrich, 2003; Frey et al., 2006; Hartmann et al., 2007; Pinard et al., 2006), 
especially in the form of partially single-stranded amplicons (Egert and Friedrich, 2005). 
The occurrence of pseudo-T-RFs has been reported to be consistently decreased by post-
amplification treatment with Klenow fragment, which restores the partially single-
stranded amplicons (Egert and Friedrich, 2005). Furthermore, single-strand-specific 
mung bean nuclease completely eliminated pseudo-T-RFs (Egert and Friedrich, 2003). 
Techniques that prevent sampling bias and artifact formation in T-RFLP analyses are 
particularly valuable for the characterization of highly complex bacterial communities, 
especially those associated with intestinal mucosa, which are poorly characterized. The 
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objectives of the current study were to: (i) use T-RFLP to empirically compare the 
efficacy of three sampling strategies on the recovery of mucosa-associated bacteria from 
the intestine of mice; (ii) assess the effect of mung bean nuclease and Klenow fragment 
on the formation of T-RFs; and (iii) apply novel statistical methods on T-RF selection, T-
RF number and group similarity assessments, providing a quantitative interpretation of T-
RFLP data.  
 
3.2 MATERIALS AND METHODS 
Mice 
Mice were housed at the small animal facility located at the Agriculture and Agri-
Food Canada (AAFC) Lethbridge Research Centre (LRC). All requirements specified by 
the Canadian Council on Animal Care (CCAC) were met, and the project was approved 
by the LRC Animal Care Committee (ACC) before commencement of the study (Animal 
Use Protocol Review 0703). Swiss Webster mice (Charles River, Montreal, QC) at 16 
weeks of age were used. 
Sample collection 
Animals (n = 9) were sedated with isofluorane and euthanized by CO2 
asphyxiation. Immediately after euthanasia, a midline incision was made and the 
intestines were aseptically exposed. Sections approximately 2 cm in length were collected 
from the terminal ileum, central portion of the cecum, and distal descending colon. 
Intestinal sections were longitudinally opened, and the mucosal surfaces were gently 
rinsed with cold sterile phosphate buffer with saline (PBS; 10 mM sodium phosphate 
buffer with 130 mM sodium chloride; pH 7.2) to remove ingesta. Three adjacent tissue 
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plugs were obtained by punching the antimesenteric side of each intestinal section with a 
3-mm-diameter biopsy punch. All samples were kept on ice and processed within 60 min 
of euthanasia. To negate spatial sampling bias, samples collected from each intestinal 
location of three arbitrarily-selected mice were pooled to comprise each of the three 
replicates (Figure 3.1). 
Sampling methods 
Three sampling methods were evaluated. For method one (i.e. the hand wash 
method), bacteria were washed from mucosal surfaces using the protocol of Gong et al. 
(2002), with minor modifications. Briefly, 1 mL of PBS containing 0.1% (v/v) Tween 80 
was added to each of three replicate samples, samples were vigorously shaken by hand 
for 1 min, and the resultant wash solutions were transferred to new tubes after a 5 s 
centrifugation pulse (13200 x g). The wash procedure was conducted three times. Tubes 
containing the washes were centrifuged at 27000 x g for 20 min to pellet bacterial cells, 
the supernatant was discarded, pellets were re-suspended in 20 L of PBS, and the three 
washes per replicate were pooled. Samples were then centrifuged again at 27000 x g for 
20 min and the supernatant was discarded. For method two (i.e. the mechanical agitation 
method), tissue samples were processed as described by Sait et al. (2003) with some 
modifications. Samples in 1 mL of PBS were agitated mechanically using a Mini-
Beadbeater (Biospec Products, Bartlesville, OK) for 20 s. The procedure was conducted 
three times, and the washes were combined and centrifuged as described above. For 
method three (i.e. direct DNA extraction), intestinal tissue samples were left untreated. 
Each method consisted of three independent replicates (n = 9 mice per method). 
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Figure 3.1. Schematic diagram of the sampling process applied to each intestinal location 
(i.e. terminal ileum, largest portion of cecum and descending colon) of mice in this study, 
with the purpose of negating spatial bias. Each pool of three tissue plugs comprised one 
replicate. This process was conducted three times to comprise the three replicates used in 
the study (i.e. nine animals per method). 
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Genomic DNA extraction  
Total genomic DNA was extracted from all samples using the protocol for Gram-
positive bacteria of the DNeasy Blood & Tissue Kit, according to the manufacturer’s 
recommendations (Qiagen Sciences Inc., Germantown, MD). Cells recovered using the 
hand and mechanical washing methods were incubated in enzymatic lysis buffer at 37 °C 
for 30 min, whereas samples for direct DNA extraction were incubated for 90 min in the 
lysis buffer. All samples were eluted with 50 µL of optima water and genomic DNA was 
verified by electrophoresis in a 1% Tris-borate-EDTA (TBE) agarose gel.  
Bacterial community DNA amplification 
DNA encoding the 16S rRNA gene was amplified by PCR. Reaction mixtures 
consisted of 2 L (10 ng) of genomic DNA, 1X PCR buffer, 0.2 mM of each 
deoxynucleoside triphosphate, 0.1 g L-1 of acetylated bovine serum albumin (Promega, 
Madison, WI), 0.625 U of Taq DNA polymerase (Qiagen Sciences Inc.), 0.5 M of the 
universal eubacterial primers, 5’ FAM (6-carboxyfluorescein)-labeled 27f (5’-
AGAGTTTGATCCTGGCTCAG-3’) and 1492r (5’-GGTTACCTTGTTACGACTT-3’), 
and optima water to a final volume of 25 L. PCR conditions were 95 °C for 15 min; 30 
cycles consisting of 94 °C for 30 s, 50 °C for 1 min and 30 s, and 72 °C for 1 min; and a 
final extension period at 72 °C for 10 min. All PCR reactions were performed in 
triplicate, pooled, purified using QIAquick PCR-purification Kit (Qiagen Sciences Inc.), 
and eluted with optima water. Samples were quantified by agarose gel electrophoresis 
(1% TBE agarose) relative to a 100 bp DNA ladder (Promega). A gel purification kit 
(Qiagen Sciences, Inc.) was used to isolate the  1500 bp amplicons in samples in which 
non-specific amplification occurred.  
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Restriction of bacterial community DNA 
Digestions were carried out in duplicate in a mixture containing 75 ng of the 
purified PCR-product, 3 U of restriction endonuclease HaeIII (Invitrogen Corp., 
Carlsbad, CA), 2.5 L of enzyme buffer, and optima water (final volume 25 L). 
Samples were incubated at 37 oC for 2 h in the dark, and the reaction was stopped by 
ethanol precipitation.  
Capillary gel electrophoresis and fragment size determination 
Samples were air-dried overnight in the dark after ethanol precipitation, 
resuspended in 9.25 L of Hi-Di formamide and 0.25 L of LIZ500 size standard marker 
(Applied Biosystems, Foster City, CA), denatured at 95 oC for 3 min, and immediately 
placed on ice. Fluorescently-labelled T-RFs were separated in POP7 polymer using a 
3130 Genetic Analyzer (Applied Biosystems-Hitachi). 
Enzymatic treatment of single-stranded DNA artifacts 
DNA extracted from cecal samples (i.e. hand wash, mechanical wash, and direct 
extraction) was used, and each method was replicated three times. To assess the 
occurrence of single-stranded artifacts (i.e. pseudo-T-RFs), bacterial community DNA 
was treated with mung-bean nuclease and Klenow fragment before restriction digestion. 
The resultant T-RFLP community profiles were compared to those obtained from DNA 
subjected directly to restriction digestion after purification and quantification. Protocols 
were performed as described previously for mung-bean nuclease (Egert and Friedrich, 
2003) and Klenow fragment (Egert and Friedrich, 2005). Digestion with mung-bean 
nuclease was stopped by ethanol precipitation, and samples treated with Klenow 
fragment were purified using QIAquick PCR-purification kit (Qiagen Sciences Inc.) 
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immediately after incubation. Amplification of community DNA, restriction digestion, 
capillary gel electrophoresis, and fragment size determination were performed as 
described above. 
T-RFLP electropherograms 
Two electropherograms (i.e. separate runs) represented by peaks were obtained per 
sample; each electropherogram was analyzed separately using GeneMapper software 
Version 4.0 (Applied Biosystems) with the Local Southern peak calling method. 
Fragment sizes were assigned to bins (i.e. operational taxonomic units) with a resolution 
of 1 bp each using a rounding method (Dunbar et al., 2001), where peaks that differed by 
less than 0.5 bp were considered identical. Manual binning was also performed on bins 
generated by the software that were less than 1 bp in length. A baseline for peak-
detection in fluorescence units by the software was assigned as zero, meaning that every 
peak would be detected and represented on the electropherograms. 
Statistical Analyses 
To prepare data for statistical analysis of T-RFs (i.e. “true peaks”), the presence or 
absence of peaks ranging from 50 to 500 bp, as well as peak height and peak area were 
determined for each replicate. Data was analyzed using SAS (SAS Institute Inc., Cary, 
NC). Analysis was based on a statistical method for identification of T-RFs as previously 
described (Abdo et al., 2006). T-RFs were detected based on variance, which was 
calculated by assuming that the true mean of the background noise height was zero. Data 
points that were larger than three standard deviations were identified as T-RFs and 
assigned the value one; pseudo-T-RFs (i.e. “false peaks”; Egert and Friedrich, 2003), 
were assigned the value zero, and were detected either by variance or by replicate 
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comparison (i.e. if a T-RF was detected in only one of the two replicates, it was 
considered a pseudo-T-RF). The SAS program written is provided in Appendix one. The 
binary dataset (i.e. 1/0 values) obtained from the SAS analysis was imported to 
Bionumerics software version 5.1 (Applied Maths Inc., Austin, TX) for cluster and 
genetic similarity analyses. Cluster analysis was performed by using the Dice coefficient, 
and unweighted pair-group methods with arithmetic means (UPGMA). 
To test the statistical significance of each group, multivariate analysis was 
performed by grouping the treatment replicates within each intestinal location, and 
comparing the within- and between-group similarities with randomization tests (i.e. re-
sampling by statistical bootstrapping) within the Bionumerics software (Applied Maths 
Inc.). The test determined significance among treatments based on comparisons between 
overall and group similarity averages. The script was set for 1000 iterations (i.e. re-
samplings). The P-values for this analysis represented how often the randomized average 
was higher than the observed group average, based on pairwise similarity measures 
(Kropf et al., 2004).  
An analysis of variance (ANOVA) for occurrence of T-RFs and for total peak area 
was performed as a completely randomized design, using the MIXED procedure of SAS, 
with location, treatment, and their interaction included in the model as fixed effects. Least 
squares were generated for significant effects and Fisher’s protected least significant 
difference test was used to compare differences among means of interest. The 
UNVARIATE procedure of SAS was used to produce normal probability plots to check 
for normality and outliers. Obvious outliers were removed before completion of the final 
analysis.  
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3.3 RESULTS 
Amplification of 16S rRNA gene from tissue plugs and cell pellets 
It was not possible to generate enough DNA for mung-bean nuclease and Klenow 
fragment reactions from all ileal and descending colon samples. Despite yielding a much 
lower concentration of genomic DNA, cell pellets generated from mechanical and hand 
washing produced similar 16S rRNA gene amplicon concentration to that produced from 
whole tissue samples (data not shown). Extraction of DNA from cell pellets generated 
from the washes did not decrease non-specific amplification relative to the direct method 
(data not shown).  
Bacterial communities recovered from different sampling methods 
Diverse bacterial communities in association with intestinal mucosa were observed 
in the murine terminal ileum, cecum, and descending colon of mice using T-RFLP, 
regardless of the sampling method employed (Figure 3.2, A; all peaks shown). For 
analysis purposes, pseudo-T-RFs were removed and samples from each intestinal 
location were grouped, generating dendrograms containing pairwise similarity measures 
(Figure 3.2, B). Composition of bacterial communities associated with mucosa within the 
colon, but not the ileum or cecum, were similar for the hand wash method among 
replicates (Figure 3.2, B).  
The hand wash method applied to colonic mucosal samples generated distinct 
(P=0.03) T-RFLP community profiles (Table 3.1). However, in the ileum and cecum, 
there was no difference (P0.05) in T-RFLP communities among the hand wash, 
mechanical wash, or direct methods. 
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Figure 3.2. (A) T-RFLP profiles (16S rRNA gene) of mucosa-associated bacterial 
communities from the murine intestine before statistical detection of T-RFs (i.e. no 
threshold applied). The three replicates per treatment are overlaid. (B) dendrograms of 
bacterial community relatedness generated from the binary data containing true bacterial 
T-RFs; T-RFLP patterns were analyzed by Dice’s coefficient (>50% mean) and UPGMA 
algorithm for cluster analysis. Acronyms on (A) and (B) represent the sampling method 
applied to recover bacterial DNA from tissue plugs (sampling method): direct DNA 
extraction (DE); hand-washing with PBS containing Tween 80 (HW); mechanical 
agitation with PBS (MA). Numbers on (B) represent each of the replicates. 
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Based on analysis of variance, T-RF number did not differ among sampling 
methods as a function of the intestinal location (P=0.21), and sampling method alone did 
not differ (P=0.45) among the three methods. However, there was a difference in T-RF 
number (P0.001) among intestinal locations; more T-RFs (P0.05) were observed from 
cecal mucosa (58.4  3.2) than from the other two sites, and more T-RFs (P0.05) were 
observed from the ileal mucosa (27.1  3.9) relative to the descending colon (17.6  3.0). 
Occurrence of pseudo-T-RFs 
Peaks generated from samples treated with mung bean nuclease had overall weaker 
fluorescence when compared to those generated from Klenow-treated and control 
samples (Figure 3.3). The total peak area (relative fluorescent units) from the mung bean 
nuclease-treated samples (1.9 x 105  4.1 x 104) was 47.1% lower (P<0.05) than the 
direct-extracted samples (3.5 x 105  6.4 x 104), and 53.3% lower (P<0.05) than the 
Klenow fragment-treated samples (4.2 x 105  1.2 x 105). Nevertheless, differences in 
community profiles among the untreated, Klenow fragment, and mung bean nuclease 
treatments did not differ (P>0.05). Furthermore, there was no difference in T-RF number 
among the treatments (P=0.13), sampling method (P=0.81), or treatment as a function of 
sampling method (P=0.98). 
 
3.4 DISCUSSION 
In this study, three tissue plugs from each intestinal location (i.e. ileum, cecum, and 
descending colon) were collected and subsequently combined to ensure spatial 
consistency from these locations, and thereby facilitate an accurate comparison of  
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Figure 3.3. T-RFs of mucosa-associated bacteria from the murine cecum (i.e. no 
threshold applied). Untreated controls (UC), treatment with Klenow fragment (KF) and 
mung bean nuclease (MB) before restriction digestion. Each electropherogram contains 
nine replicates of the specified enzymatic treatment, three from each sampling method 
applied before DNA extraction (i.e. direct extraction, hand wash and mechanical wash). 
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treatments on microbial communities. Nonetheless, there was considerable variability 
among replicates, suggesting that a significant degree of inter-animal variability in    
mucosa-associated communities of the ileum and cecum occurred, despite the similarity 
in diet, environment, and genetics of the mice used in the current study. 
Samples from the descending colon subjected to hand washes generated distinct T-
RFLP profiles, and fewer T-RFs than the direct and mechanical wash methods; therefore, 
it was inferred that the hand washing method provided an underestimation of diversity of 
bacteria associated with the mucosa in this location. This effect was location-specific, as 
there was no difference in T-RFLP profiles among the three treatments for samples 
obtained from the cecum or ileum. These findings contrasted with those of Li et al. 
(2003), who reported that > 93% of bacterial cells were released from the colonic 
mucosa, as well as from the ileum and cecum, by hand washing the tissues with buffer 
containing Tween 80. They compared the number of bacterial cells released from the 
mucosa by washing, relative to those scraped from the mucosa with a glass slide and 
enumerated by epifluorescence microscopy. However, they did not assess the efficacy of 
the scraping method in removing and enumerating mucosa-associated bacteria. It was 
concluded that DNA extracted directly from tissue provided an accurate and reliable 
representation of bacterial communities associated with the intestinal mucosa. Whole 
tissue, however, may hamper the disruption of bacterial cells in the enzymatic lysis 
(Ingrassia et al., 2001). Increasing the enzymatic lysis period, as in the current study, 
negated this possibility (More et al., 1994). In addition, DNA extracted directly from 
tissue may also generate pseudo-T-RFs as a result of non-specific amplification of 
mammalian DNA. Amplification of the 18S rRNA gene using 16S rRNA gene primers 
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was previously encountered in our laboratory (data not published). However, 16S rRNA 
gene amplicons were gel-purified to ensure that non-target amplicons were eliminated. 
Interestingly, dislodgement of bacterial cells from the mucosa by washing was not 
effective in preventing non-specific amplification, and gel purification was also required 
for washed samples. Given the considerable logistical advantages of the direct method 
(i.e. tissues can be archived for later processing), combined with amplification efficacy 
equivalent to the wash methods, it was concluded that the direct tissue method was 
preferred for T-RFLP analysis of mucosa-associated bacteria of the intestine. 
DNA treated with Klenow fragment and mung bean nuclease did not generate 
significantly different T-RFLP profiles, indicating that single-stranded DNA artifacts 
were either not eliminated or their presence was not frequent enough to significantly 
affect the comparative analysis. Mung bean nuclease decreased the DNA concentration, 
and as with the Klenow fragment, required a relatively large amount of DNA for the 
reactions (i.e. 1 g). Therefore, their use for routine characterizations of mucosa-
associated bacteria, which are not always abundant (e.g. particularly in the small 
intestine), is not practical. Although Klenow fragment and mung bean nuclease were not 
beneficial for comparative analysis of intestinal mucosa-associated bacteria in the present 
study, their use should be considered when it is possible to produce enough DNA for the 
reactions, and for more specific applications, as the analysis of sequence diversity for 
cloning (Egert and Friedrich, 2005). 
Despite being a very powerful and high-throughput technique for analysis of 
microbial communities, the T-RFLP method is still in development. Several key issues 
must be addressed, especially when the objective of experimentation is to widely 
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characterize community structure and dynamics. Appropriate T-RF selection and 
alignment for the analysis, as well as accurate diversity (Blackwood et al., 2007) and 
abundance (Frey et al., 2006) assessments of microbial profiling remain issues of 
concern. Determination of group significance by randomization tests using pairwise 
similarity measures (Kropf et al., 2004), as well as variance and ordination analysis 
(Culman et al., 2008) have proven effective for comparative analysis of bacterial 
community fingerprinting data. In the current study, a statistical method based on 
variance for selecting T-RFs was used, combined with statistical methods of 
randomization and variance to determine group significance and T-RF occurrence, 
thereby providing a comprehensive, reproducible, and reliable analysis of T-RFLP 
profiles. Currently, most T-RFLP data analyses are based on qualitative assessments of 
the electropherograms which are commonly generated by establishing a fixed-percentage 
threshold (Dunbar et al., 2001) to exclude the background noise (i.e. “false peaks”). 
Statistical detection of T-RFs negates the possibility of excluding small reproducible 
peaks (Abdo et al., 2006). 
The present findings emphasized the utility of the T-RFLP method for comparative 
analyses of complex bacterial communities. Using quantitative assessments of the 
electropherograms and dendrograms, T-RFLP analysis were applied to characterize 
complex bacterial communities associated with the intestinal mucosa of mice. In addition 
to considerable logistical advantages, direct extraction of DNA from intestinal tissues 
provided equivalent representation of bacterial communities associated with intestinal 
mucosa. Furthermore, it was demonstrated that neither Klenow fragment nor mung bean 
nuclease were crucial for T-RFLP analysis of intestinal bacterial communities.  
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CHAPTER FOUR 
Effect of long-term oral administration of non-therapeutic doses of a model 
antimicrobial growth promoter on the intestinal microbiota composition of cattle 
and mice 
 
ABSTRACT 
Despite the multitude of studies regarding the prevalence of resistant bacteria in 
animals administered AGP, little attention has been directed towards determining the true 
mode of action of AGP, and its impact on the intestinal microbiota. In this study, the 
effect of orally administered non-therapeutic CTC and sulfamethazine (AS700) on the 
composition of the intestinal microbiota of cattle was examined by T-RFLP analysis. 
Bacterial communities associated with the intestinal mucosa differed from those 
associated with the adjacent digesta in beef cattle. However, administration of AS700 did 
not affect the composition of bacterial communities associated with the mucosa or digesta 
of cattle, with exception of the mucosa of the proximal jejunum. Similarly to cattle, non-
therapeutic administration of CTC administered to mice did not substantially affect 
bacterial communities associated with the murine intestinal mucosa. It was also 
demonstrated that bacterial community composition varied along the intestinal tract of 
cattle and mice, with an obvious distinction between the small and large intestine. The 
results from this study do not support the microbiota modulation hypothesis as the 
primary mechanism of action of growth promotion by AGP, and indicate that AGP may 
function in an alternate manner. 
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4.1 INTRODUCTION 
Antimicrobial agents from the tetracycline class are widely used because of their 
favorable effects, such as absence of major side effects and broad-spectrum of action, and 
their activity against a wide range of Gram-positive and Gram-negative bacteria, 
including chlamydiae, mycoplasmas, and rickettsiae (Chopra and Roberts, 2001). 
Chlortetracycline was the first of the tetracycline class of AMA to be discovered 
(Duggar, 1948), and has been widely used at therapeutic concentrations to treat infections 
in human and veterinary medicine, and at non-therapeutic concentrations to prevent 
infections and promote growth in livestock (Chopra and Roberts, 2001). Unfortunately, 
the extensive use of CTC in human and veterinary medicine, as well as in agriculture 
(Chopra and Roberts, 2001), has resulted in elevated selective pressure for AMR in 
enteric pathogens (Alexander et al., 2008; Emborg et al., 2003; Inglis et al., 2005), 
substantially decreasing the effectiveness of CTC (Chopra and Roberts, 2001). Resistance 
to tetracyclines in bacteria has emerged due to the acquisition of resistant determinants, 
such as tet genes (Burdett et al., 1982). The long-term administration of AGP, including 
CTC and sulfamethazine in livestock, is generally regarded as a primary reason for the 
high prevalence of AMR (McEwen and Fedorka-Cray, 2002; Shea et al., 2004). A 
concern is that AGP are still widely used in North American livestock production, and 
many AMA used in human medicine and as AGP belong to the same class (i.e. 
sulfonamide, tetracycline, penicillin, macrolide, aminoglycoside, lincosamide; HC, 
2002). The National Animal Health Monitoring System (NAHMS) reported that 52% of 
all United States feedlots in 1999 (NAHMS, 1999) and 43% of all United States swine 
production nursery sites in 2006 (NAHMS, 2006) administered CTC in water or feed. 
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Measures to restrict AGP use in North America, will soon be implemented, as has already 
occurred in the European Union (Castanon, 2007). The prevalence of AMR in specific 
zoonotic pathogens and pathogen surrogates due to AGP administration in livestock has 
been the subject of numerous studies (Conly, 2002; McEwen and Fedorka-Cray, 2002). 
However, limited research has examined the effect of AGP on the composition of 
livestock microbiota or on AMR in commensal intestinal bacteria.  
T-RFLP is a cultivation-independent community fingerprinting technique that has 
been successfully used to characterize and explore complex microbial communities 
(Dunbar et al., 2001; Weng et al., 2006). The relative simplicity of T-RFLP to explore 
community structures is a result of 16S rRNA gene sequence polymorphisms (Liu et al., 
1997). Recent advancements in statistical analysis of T-RFLP data (Abdo et al., 2006; 
Costa et al., 2009; Culman et al., 2009) enable a highly comprehensive and practical 
comparative assessment of the intestinal microbiota composition among intestinal 
locations and experimental treatments.  
Examining potential effects of AGP on the intestinal microbiota is critical to 
unraveling the mechanisms of action of AGP, and will assist in the development of 
alternatives. Despite being the most accepted hypothesis (Dibner and Richards, 2005), 
modulation of the microbiota by AGP has not been thoroughly tested. Furthermore, it has 
been suggested that low concentrations of AGP would not be expected to exert a 
substantive effect on the composition of the intestinal microbiota (Niewold, 2007). The 
objective of the present study was to assess the effect of non-therapeutic concentrations 
of orally administered CTC and sulfamethazine (i.e. AS700) on the composition of the 
cattle intestinal microbiota using T-RFLP analysis. In addition, doses of CTC given to 
 61
cattle were extrapolated for use in a murine model, and the effect of three non-therapeutic 
doses of CTC on the composition of bacterial communities associated with the intestinal 
mucosa of mice were also assessed. The following hypothesis was tested: the 
administration of model AGP (i.e. AS700 for cattle, or CTC for mice) will not impart 
substantial modifications to the intestinal microbiota of cattle and mice.  
 
4.2 MATERIALS AND METHODS 
Cattle 
Beef cattle were housed in an experimental feedlot located at the AAFC LRC. All 
of the animals were cared for according to the guidelines set out by the CCAC. Cattle 
originated from a common location and did not receive AMA before commencement of 
the experiment.  
Treatments of cattle 
Upon arrival at the feedlot, cattle were randomly assigned to one of two treatments: (1) 
Control, which received no AMA; and (2) AS700, which received 350 mg hd-1 d-1 CTC 
and 350 mg hd-1 d-1 sulfamethazine (Aureo S®-700 G, Alpharma Inc., NJ). AS700 is 
commonly used in the Canadian beef industry, and was fed at the concentration 
recommended by the manufacturer. Each experimental unit consisted of a separate pen 
containing ten steers, and each treatment was replicated five times. Water troughs were 
shared between adjacent pens, but treatments were arranged in a manner so that only 
cattle that received the same antimicrobial agent shared water troughs (Figure 4.1). Steers 
entering the feedlot were fed a forage-based diet for the first 115 d consisting of 70%  
 
 62
 
 
Figure 4.1. Schematic representation of the experimental units and the treatments applied 
in this study. Cross-hatched rectangles with a number correspond to a separate pen in the 
experimental feedlot, and represent one experimental unit. 
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barley silage, 25% barley grain and 5% (dry matter basis) supplement containing 
vitamins and minerals (i.e. backgrounding period). Cattle were subsequently switched 
from the forage-based diet to a grain-based diet (85% barley, 10% barley silage, 5% 
supplement) for 21 d, and then were maintained on a grain-based diet for an additional 
179 d (i.e. finishing period). Cattle were fed once daily in a manner that ensured that all 
feed that was allotted to each pen was consumed. AS700 was introduced into the diets 5 d 
after cattle arrived at the feedlot, and they were included in the forage-based diet for 56 d 
thereafter. The AMA were subsequently removed from the diet for 56 d and reintroduced 
for additional 42 d when the grain-based diet was fed. AS700 was administered in the 
diet until 28 days before slaughter. To avoid cross contamination, AMA were mixed with 
5 kg of a supplement containing minerals and vitamins, and the mixture was manually 
spread over the surface of feed within each of the appropriate pens during the morning 
feeding. All animals in the pen were capable of feeding at the feed trough at the same 
time.  
Collection of digesta and intestinal tissues from cattle 
One animal per replicate from each of the Control and AS700 treatments was 
selected for sampling in the abattoir (n = five animals per treatment); the abattoir was a 
provincially inspected, medium-capacity plant (Ben’s Quality Meats, Picture Butte, AB). 
Animals were transported to the abattoir on the evening prior to slaughter, and those from 
the AS700 treatment were transported 1 d after animals from the Control treatment. At 
the abattoir, animals were maintained on a barley silage diet, and were humanely 
euthanized. The intestinal tract of each animal was removed approximately 10 min after 
euthanasia, and placed on a clean sheet of plastic on a cool cement floor in the abattoir. 
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Nine intestinal sections, each approximately 20 cm long, were obtained from each animal 
at the following locations: (i) descending portion of the duodenum (i.e. following the 
cranial flexure); (ii) proximal jejunum; (iii) central jejunum; (iv) distal jejunum; (v) ileum 
( 10 cm before the ileal-cecal junction); (vi) terminus of the cecum; (vii) central flexure 
of the ascending colon; (viii) descending colon ( 20 cm before the sigmoid colon), and 
(ix) rectum. Before excision of the intestinal sections, bilateral ligatures were applied 
adjacent to the excision site to minimize external contamination of the tissues with 
digesta. Tissues samples were placed in individual bags on ice and processed within 6 h 
of collection. Intestinal sections were aseptically excised longitudinally and digesta was 
aseptically removed. Digesta from each sample was weighed (200 mg ± 20 mg), and 
placed in DNA-free tubes. Following removal of the majority of digesta, the mucosal 
surface within each intestinal section was gently washed with chilled sterile PBS, taking 
care to remove residual digesta while minimizing disruption of mucus on the mucosal 
surface. Mucosal sections were removed with a sterile 3-mm-diameter Biopsy Acu-Punch 
(CDMV) and individual plugs were placed in DNA-free tubes. Digesta and mucosal 
plugs were stored at -20 ºC until processed.  
Mice 
Twelve C57BL/6J 4 week-old female mice were purchased from Charles River 
Laboratories International, Inc. (Montreal, QC). Mice were housed at the small animal 
facility located at the AAFC LRC. All requirements specified by the CCAC were met, 
and the project was approved by the LRC ACC before commencement of the study 
(Animal Use Protocol Review 0703). Mice were maintained individually in filter-topped 
cages under specific pathogen free (SPF) conditions, and transferred to sterile cages daily 
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during the experiment. All mice were maintained on a 12 h light/dark cycle and had free 
access to sterile autoclaved food (Prolab RMH 3500 Autoclavable; PMI Nutrition 
International, Brentwood, MO) and water. 
Treatments of mice 
Mice were randomly assigned to each treatment (n = three mice per treatment). 
Mice from CTC treatments received 2, 8, or 32 mg L-1 of CTC (Sigma, St. Louis, MO) 
added to autoclaved water, whereas mice from the Control treatment received only 
autoclaved water. CTC was administered for 3 weeks; fresh CTC solutions were provided 
twice a week. Sucrose (5% w/v; Sigma) was added to the water for all treatments, and all 
water bottles were covered with aluminum foil.  
The three doses of CTC used in mice were extrapolated from non-therapeutic doses 
administered in cattle using three approaches. The first approach was based on body 
weight ratio, which is approximately 20 g in mice versus 400 kg in beef cattle (ratio of 
1/8000). Based on this ratio and a non-therapeutic dose of 75 mg d-1 in cattle, the average 
daily intake in mice would be approximately 9 µg (achieved with a water concentration 
of 2 mg L-1). The second approach was based on the ratio of non-therapeutic to 
therapeutic doses of CTC in cattle (approximately 75 versus 6000 mg d-1, ratio of 1/80). 
Using this ratio and an average therapeutic dose of CTC in mice of 640 mg L-1, a dose of 
8 mg L-1 was obtained. Finally, since average therapeutic doses of CTC in mice are 
approximately four-fold higher than those used in cattle (approximately 60 versus 15 mg 
kg-1 d-1), a third dose, four-fold higher (32 mg L-1), was selected. 
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Collection of feces and intestinal tissues from mice 
Fecal samples of mice from Control and CTC treatments were collected at 1, 8, 12, 
and 20 d after commencement of CTC administration. On day 21, mice were humanely 
euthanized by CO2 asphyxiation following sedation by isofluorane (Halocarbon Products 
Corporation, River Edge, NJ). The GI tract was removed, and 2 cm sections of the 
proximal duodenum, central jejunum, ileum (immediately before the ileal-cecal junction), 
terminus of the cecum, ascending and descending colon were aseptically collected. Each 
intestinal section was longitudinally excised, rinsed with chilled sterile PBS, and mucosal 
samples were collected with a sterile 3-mm-diameter Biopsy Acu-Punch (CDMV, St. 
Hyacinthe, QC).  
Estimation of residual CTC in murine feces 
To estimate the concentration of residual CTC in fecal samples, an agar diffusion 
method was performed as described previously (Brooks et al., 2009), with the following 
modifications. Residual CTC was extracted by suspending known amounts (10-50 mg) of 
murine feces in 0.01 N HCl, which was followed by homogenization and centrifugation 
(12,000 x g, 20 min). The supernatant (i.e. acidic extract) was recovered, sterilized by 
filtration through a 0.2 m filter (Nalgene, Rochester, NY), and added to Triptic Soy 
Agar (TSA; BD, Franklin Lakes, NJ) in Petri dishes to which cells of Staphylococcus 
aureus strain ATCC 29213 were distributed over the agar surface. S. aureus cells were 
obtained from an overnight culture on TSA at 37 oC. Cells were suspended in Columbia 
broth (BD) and adjusted to an optical density (O.D.) equivalent to a 0.5 McFarland 
standard (O.D. 0.1 at λ 600 nm). A 100 µL aliquot of the suspension of S. aureus cells 
were then spread on TSA. Regular spaced wells were perforated in the agar with a sterile 
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cork borer (4-mm diameter), and 50 µL of the acidic extract from feces was added to 
each well. Assays were carried out in triplicate for each sample, and the zones of 
inhibition in the S. aureus lawn were measured following 18 h of incubation at 37 oC 
(Appendix two). The diameters of the inhibition zones were measured in two directions at 
90o to each other and an average value was calculated. Estimation of CTC concentrations 
in fecal samples was interpolated from standard curves of inhibitions zones obtained from 
wells to which known concentrations of CTC were added.  
Characterization of bacterial communities by T-RFLP analysis2 
Extraction of community DNA from intestinal samples, amplification of bacterial 
community 16S rDNA, restriction digestion of amplified rDNA, capillary gel 
electrophoresis, and analysis of T-RFLP electropherograms were conducted as described 
in Chapter 3. Extraction of community DNA from cattle digesta samples was performed 
with the QIAamp DNA Stool Kit according to the manufacturer’s recommendations 
(Qiagen Sciences Inc., Germantown, MD).   
Statistical analyses 
Statistical analysis for selection of T-RFs (“true peaks”) was performed with T-
REX software for the analysis of T-RFLP data (Culman et al., 2009), which provided 
highly automated processing of the T-RFLP data. The T-REX software was used for 
analyses of presence/absence of T-RFs and relative abundance; the latter used peak 
height data (relative fluorescence). Matrices produced by the T-REX software were 
imported into Bionumerics for cluster analyses and group significance tests, as described 
in Chapter 3. Cluster analysis for the relative abundance data (i.e. numerical data), was 
                                                 
2 Kristen Reti (University of Lethbridge) conducted the T-RFLP analysis for the beef cattle component of 
this study. 
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performed with the Bray-Curtis coefficient, which corresponds to the Dice coefficient 
that is applied to binary data (i.e. presence/absence of T-RFs). Non-metric multi-
dimensional scaling analysis (NMS) of the similarity matrices obtained from 
Bionumerics analysis was performed in the SAS software (SAS Institute Inc., Cary, NC). 
Group significance tests were applied to compare the composition of the microbiota 
among intestinal locations, and to compare communities associated with the digesta and 
mucosa of the cattle intestine. Samples were combined across locations that were not 
significantly different for subsequent comparisons of microbiota composition between 
treatments with NMS plots and group significance test. Venn diagrams with unique, 
common, and shared T-RFs were constructed with a macro in Excel software (Microsoft 
Corp., Redmond, Washington) to assess commonality of bacterial communities among 
treatments and between mucosa and digesta of cattle with information obtained from T-
REX.  
 
4.3 RESULTS 
Distinctive microbiota composition along the intestinal tract of cattle 
Analysis of T-RFLP data from digesta and mucosa of cattle revealed a distinctive 
microbiota composition between the small (P0.001) and large intestine (P0.001) for 
Control and AS700 treatments (Figure 4.2). For the mucosa, differences in microbiota 
composition were not observed among individual locations of the small intestine 
(P0.05), and neither between the cecum and descending colon (P0.05), regardless of 
treatment. However, the composition of the microbiota of the cecum (P=0.041) and 
rectum (P0.001) were different than those of the descending colon. Thus, the locations 
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Figure 4.2. Non-metric multi-dimensional scaling applied to presence/absence T-RFLP 
data from mucosa and digesta of small and large intestine cattle. (A) mucosa, Control 
treatment; (B) mucosa, AS700 treatment; (C) digesta, Control treatment; and (D) digesta, 
AS700 treatment. (SI) small intestine; (LI) large intestine; (PJ) proximal jejunum; (CE) 
cecum; (AC) ascending colon; (DC) descending colon; (RE) rectum. Dashed-line 
ellipsoids in A and B contain mainly samples from the small intestine, with a few outliers 
from the large intestine. Closed-line ellipsoids in A and B comprise exclusively samples 
of the large intestine, with exception of one outlier in A. The dashed-line and closed-line 
ellipsoids in C and D represent the formation of unique groups (P0.05) for the small and 
large intestine, respectively. 
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defined for comparison of treatments for cattle mucosa were: (i) small intestine, (ii) 
cecum, (iii) ascending colon, (iv) descending colon, and (iv) rectum. For digesta, there 
was no significant difference in microbiota composition between individual intestinal 
locations. Thus, the locations defined for comparison of treatments for cattle digesta 
were: i) small intestine and ii) large intestine. 
AS700 treatment did not consistently affect intestinal microbiota of cattle 
The composition of the microbiota varied amongst individual animals (Figure 4.3). 
There was no difference (P0.05) between Control and AS700 treatments in the 
composition of the microbiota in the digesta of either the small or large intestine (Table 
4.1, Figure 4.3). Similarly, there was no difference (P0.05) between treatments in the 
composition of the microbiota associated with mucosa of the duodenum, central jejunum, 
distal jejunum, ileum, cecum, ascending colon, descending colon, and rectum. However, 
the composition of the microbiota associated with mucosa of the proximal jejunum 
differed (P0.05) between the two treatments (Table 4.1, Figure 4.3).  
Microbiota composition differed between mucosa and digesta of the cattle intestine 
Based on analysis of presence/absence T-RFLP data, the composition of the 
microbiota in digesta differed (P0.05) from that in association with adjacent mucosa in 
the small (i.e. distal jejunum and ileum) and large (i.e. cecum, descending colon) 
intestines (Figure 4.4, A, B), regardless of treatment. Venn diagram analysis further 
illustrated this difference (Figure 4.5). Similarly to the presence/absence T-RFLP data, 
analysis of the relative abundance T-RFLP data revealed differences (P0.05) between 
bacterial communities associated with mucosa and in digesta (Figure 4.4, C, D).  
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Figure 4.3. Non-metric multi-dimensional scaling applied to presence/absence T-RFLP 
profiles from digesta and mucosa of the cattle intestine to compare the composition of 
bacterial communities between treatments. (A) mucosa, small intestine; (B) mucosa, 
large intestine; (C) digesta, small intestine; and (D) digesta, large intestine. (SI) small 
intestine; (PJ) proximal jejunum; (CE) cecum; (AC) ascending colon; (DC) descending 
colon; and (RE) rectum. No difference in microbiota composition was observed between 
treatments with the group significance test, with the exception of the mucosa of the 
proximal jejunum. Each data point corresponds to one individual sample. Inter-animal 
variability is observed by the dispersion of data points from the same treatment group. 
 
 
 
 72
Table 4.1. Group significance analysis of T-RFLP community profiles 
(presence/absence data) by pairwise comparisons within cattle intestinal 
communities associated with digesta and mucosal samples  
 P values 
Digesta Control AS700 
 Small intestine 0.860 0.308 
 Large intestine 0.607 0.060 
Mucosa   
 Duodenum 0.300 0.834 
 Proximal jejunum 0.033* 0.066 
 Central jejunum 0.098 0.267 
 Distal jejunum 0.831 0.653 
 Ileum 0.834 0.171 
 Cecum 0.587 0.512 
 Ascending colon 0.074 0.751 
 Descending colon 0.343 0.955 
 Rectum 0.672 0.215 
*Values represent unique groups 
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Figure 4.4. Non-metric multi-dimensional scaling applied to presence/absence and 
relative abundance T-RFLP profiles to compare bacterial community composition 
between mucosa () and digesta () from the small and large intestine of cattle. (A) 
presence/absence data, small intestine; (B) presence/absence data, large intestine; (C) 
relative abundance data, small intestine; and (D) relative abundance data, large intestine. 
Closed-line ellipsoids represent unique groups (P0.05). 
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Figure 4.5. Venn diagram illustrating the distribution of unique, shared, and common T-
RFs among intestinal mucosa and digesta of cattle from the Control and AS700 
treatment. T-RFs were combined across animals from the same treatment (total = 178 T-
RFs). (A) digesta, Control treatment; (B) digesta, AS700 treatment; (C) mucosa, Control 
treatment; (D) mucosa, AS700 treatment. 
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Distinctive microbiota composition along the intestinal tract of mice 
Group significance test and ordination of presence/absence T-RFLP data by NMS 
revealed the formation of three distinct communities along the mouse intestinal tract: the 
upper small intestine (i.e. duodenum and jejunum), ileum, and large intestine (i.e. cecum, 
proximal colon, and distal colon; Figure 4.6). Bacterial communities associated with the  
mucosa of the ileum did not possess a unique microbiota composition for either treatment 
(P0.05, Figure 4.6). Additionally, communities associated with mucosa in the upper 
small intestine and large intestine for the Control (Figure 4.6, A) and 2 mg L-1 (Figure 
4.6, B) treatments possessed a unique microbiota composition (P0.05), whereas 
communities associated with the mucosa in the large intestine, but not the upper small 
intestine, possessed a unique microbiota composition within the 8 mg L-1 (Figure 4.6, C) 
and 32 mg L-1 (Figure 4.6, D) treatments (P0.05). No significant difference (P0.05) in 
microbiota composition was observed between the duodenum and jejunum, and neither 
among the cecum, proximal and distal colon. 
CTC treatment did not consistently affect intestinal microbiota of mice 
To assess the effect of CTC treatment on the composition of the intestinal 
microbiota, global (i.e. comparing treatments among all the defined locations; Table 4.2) 
and pairwise comparisons of T-RFLP data for the upper small intestine, ileum, and large 
intestine were performed. For the upper small intestine, the 2 mg L-1 treatment mice 
possessed a unique microbiota composition relative to the other treatments (Table 4.2, 
Figure 4.7). Pairwise comparisons revealed no difference (P0.05) among treatments in 
the upper small intestine. There was no significant difference between treatments in the 
ileum (Table 4.2, Figure 4.7). In the large intestine, both the 2 mg L-1 and 8 mg L-1  
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Figure 4.6. Non-metric multi-dimensional scaling applied to presence/absence T-RFLP 
profiles from mucosa of small and large intestine of mice. (A) Control treatment; (B) 2 
mg L-1 treatment; (C) 8 mg L-1 treatment; (D) 32 mg L-1 treatment; () upper small 
intestine (i.e. duodenum and jejunum); () ileum; and () large intestine (i.e. cecum, 
proximal and distal colon). Closed-line ellipsoids represent unique groups (P0.05). 
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Table 4.2. Group significance analysis of T-RFLP community profiles (presence/absence data) 
by global comparisons within murine intestinal communities associated with the mucosa 
Comparisons P value 
Upper small intestine  
Control versus (2 mg L-1 + 8 mg L-1 + 32 mg L-1) 0.086 
2 mg L-1 versus (Control + 8 mg L-1 + 32 mg L-1) 0.001* 
8 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.885 
32 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.137 
Ileum  
Control versus (2 mg L-1+ 8 mg L-1 + 32 mg L-1) 0.510 
2 mg L-1 versus (Control + 8 mg L-1 + 32 mg L-1) 0.073 
8 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.237 
32 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.449 
Large intestine  
Control versus (2 mg L-1 + 8 mg L-1 + 32 mg L-1) 0.100 
2 mg L-1 versus (Control + 8 mg L-1 + 32 mg L-1) <0.001* 
8 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.047* 
32 mg L-1 versus (Control + 2 mg L-1 + 32 mg L-1) 0.306 
* Values represent unique groups 
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Figure 4.7. Non-metric multi-dimensional scaling applied to presence/absence T-RFLP 
data from small (A; USI=upper small intestine; IL=ileum) and large intestine (B) of mice 
from the Control treatment, and of those that received various doses of CTC. Closed-line 
ellipsoid in (A) is composed mainly of samples from the ileum. Closed-line ellipsoid in 
(B) is composed of samples from mice that received 8 mg L-1 CTC, which formed a 
unique group when globally to the other treatments, but not when compared to the 32 mg 
L-1 treatment. Dashed-line ellipsoid in (B) is composed of samples from mice that 
received 2 mg L-1 CTC, which formed a unique group when compared to the other 
treatments by global and pairwise comparisons. 
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treatment mice possessed a unique microbiota composition relative to the other 
treatments (Table 4.2, Figure 4.7). Pairwise comparisons in the large intestine revealed 
that the 2 mg L-1 treatment mice possessed a unique (P0.05) microbiota composition 
relative to the Control, 8 mg L-1, and 32 mg L-1 treatment mice, whereas the 8 mg L-1 
treatment mice possessed a unique (P0.05) microbiota composition relative to the 
Control and 2 mg L-1 treatment mice (Figure 4.7). A considerable degree of inter-animal 
variability was observed. For instance, there was a higher similarity among samples from 
different locations within the same mouse than among samples of the same location from 
different mice (Figure 4.8, Control treatment). 
Residual CTC in murine feces 
Residual CTC was detected in acidic extracts of feces using the bacterial sensitivity 
bioassay. Mean zones of inhibition from mice administered CTC were 3.2  2.0 µg g-1 
feces of mice from the 8 mg L-1 treatment, and 19.4  3.3 µg g-1 feces of mice from the 
32 mg L-1 treatment. Residual CTC could not be detected in feces of mice from the 2 mg 
L-1 treatment. No inhibitory activity was detected in acidic extracts prepared from feces 
of mice from the Control treatment. 
 
4.4 DISCUSSION 
In the present study, oral administration of non-therapeutic concentrations of CTC 
and sulfamethazine (i.e. AS700) did not significantly affect the composition of bacterial 
communities in association with the digesta and mucosa of the cattle intestine, with 
exception of those associated with the mucosa of the proximal jejunum. Similarly, the 
highest non-therapeutic dose of CTC (i.e. 32 mg L-1) did not affect the composition of  
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Figure 4.8. Dendrogram of bacterial community relatedness generated from 
presence/absence T-RFLP data of the intestinal mucosa of mice not administered CTC. 
Cluster analysis was performed by Dice’s coefficient (50% mean) and UPGMA 
algorithm. Acronyms represent the intestinal location of each sample: (DU) duodenum; 
(JE) jejunum; (IL) ileum; (CE) cecum; (PC) proximal colon; and (DC) distal colon. 
Symbols represent individual mice that were not administered CTC: () mouse 1; () 
mouse 2; and () mouse 3. 
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bacterial communities associated with the intestinal mucosa of mice, and the 2 mg L-1and 
8 mg L-1 did not consistently affect the intestinal microbiota. These findings are not 
congruent with the microbiota modulation hypothesis as the primary mechanism of action 
of AGP (Dibner and Richards, 2005).  
Consistent with the assumption that little CTC would reach the large intestine due 
to absorption in the stomach and small intestine, oral administration of non-therapeutic 
concentrations of AS700 only affected the composition of the mucosa-associated 
microbiota of the proximal jejunum of cattle in the current study. It has been reported that 
the administration of non-therapeutic doses of CTC increased the frequency of 
tetracycline-resistant Campylobacter jejuni and C. hyointestinalis in cattle feces (Inglis et 
al., 2005), and that the oral administration of CTC concentrations as low as 1 mg L-1 to 
human-flora-associated mice resulted in an increase of cultivable tetracycline resistant 
bacterial species in the feces (Perrin-Guyomard et al., 2001). In another study, however, 
non-therapeutic CTC reduced bacterial community diversity in rat feces, but did not 
affect community abundance or the tetracycline resistance gene copy number in the 
bacterial community (Brooks et al., 2009). A recent study (16S rRNA gene libraries) 
reported that oral administration of growth-promoting doses of tylosin and virginiamycin 
did not affect the fecal community composition of swine (Kalmokoff et al., 2010). These 
researchers attributed the discrepancy of antimicrobial effects on the fecal microbiota 
between rats and swine to higher levels of endogenous resistance within the bacterial 
community of intensively raised swine. All of the above studies examined fecal 
communities, which are substantially different from bacterial communities found in the 
digesta or associated with the mucosa of the intestine (Zoetendal et al., 2002). Changes in 
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the composition of the mucosa-associated bacterial communities in the ilea of piglets due 
to the administration of non-therapeutic concentrations of CTC (i.e. by 16S rDNA library 
analysis) have been reported (Rettedal et al., 2009). However, logistical limitations of 
library analysis, coupled with high inter-animal variability, obscured conclusions as to 
the real effect on the ileal communities by CTC in this study.  
The literature regarding composition of the intestinal microbiota of cattle is scarce. 
The use of T-RFLP in the current study enabled empirical assessments of AGP effects on 
the intestinal microbiota composition, as well as a comprehensive characterization of 
murine and cattle intestinal bacterial communities along the intestinal tract. A salient 
finding of the current study was the obvious distinct difference in composition of 
bacterial communities between the digesta- and mucosa-associated microbiota of cattle, 
which is in concordance with previous findings in pigs (Pryde et al., 1999; Rettedal et al., 
2009; Simpson et al., 1999). Differences between fecal- and mucosa-associated 
microbiota have also been reported in humans (Eckburg et al., 2005; Lepage et al., 2005; 
Turnbaugh et al., 2009). The current study also revealed a clear distinction in bacterial 
community composition between the small and large intestine of mice and cattle. The GI 
tract comprises a series of various distinct anatomic organs with specific functions, which 
determine the structure and composition of the microbiota (Savage, 1977). The GI tract is 
subject to several physiologic processes, such as oxygenation, different passage rates of 
digesta (He et al., 1999), as well as the influence of the gut-associated lymphoid tissue 
(Cebra et al., 1998), which relate to the substantial heterogeneity of the microbiota along 
its length. The areas of stagnation in the flowing stream of digesta at the cecum reflect 
the development of enormous microbial communities at this location, and the decreased 
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oxygen availability along the intestinal tract is consistent with the presence of mainly 
anaerobic microbial communities in the large intestine, especially in the colon (Savage, 
1977), which distinguishes it from the small intestine. Another important component of 
the GI tract is the mucus layer, which contains antimicrobial peptides (Meyer-Hoffert et 
al., 2008), serves as nutrient source, and as protective layer from infective bacteria 
(McAuley et al., 2007) and mechanical stress, among other functions (Figure 1.3; Atuma 
et al., 2001). The association of bacteria with the mucus is intrinsic in the intestine, and 
the difference in thickness of the mucus layer along the intestinal tract (Atuma et al., 
2001) may also contribute to the heterogeneity in the microbiota composition in each 
location of the GI tract. Autochthonous (i.e. indigenous) microorganisms associated with 
the mucosal surfaces do not exclusively comprise the GI microbiota; allochthonous (i.e. 
exogenous) transients present in the digesta may also contribute to digest the host’s food 
and to provide products of fermentation that can be absorbed and used as energy sources 
by the host (Savage, 1987). Unfortunately, community assessments of digesta may not 
give a good indication of the resident microbiota due to the high level of transient 
microorganisms, especially in locations with high passage rate. In the current study, the 
microbiota associated with the small intestine of mice was more variable in composition 
among replicates than the microbiota associated with the murine large intestine. 
Furthermore, bacterial communities associated with the mucosa of the murine ileum were 
most variable, and were distinct from the mucosal microbiota of both the upper small 
intestine and the large intestine. Relative to the large intestine, it is possible that the 
microbiota of the upper small intestine in mice is comprised to a greater degree by 
allochthonous bacteria ingested by coprophagy (Savage, 1987). Accordingly, the majority 
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of antigenic exposure in the upper small intestine is thought to come from diet 
components and not bacteria, whereas the ileum and large intestine comprise additional 
antigenic load from a more abundant microbiota (MacDonald and Monteleone, 2005). 
Communities of bacteria are thought to be less diverse and with smaller populations in 
the small relative to the large intestine as a result of the faster passage rate of digesta 
(Macfarlane and Macfarlane, 2009) and reduced fermentation (Gibson et al., 1996). The 
largest numbers of bacteria in the small intestine are typically found in the ileum, 
probably due to an influx of cecal bacteria through the ileo-cecal valve (Savage, 1977).  
Varied levels of inter-animal variability were detected in the present study, despite 
the use of mice and cattle from the same breed, age, gender, and subject to the same diet 
and experimental conditions. Inter-individual variability has been previously reported in 
the microbiota of cattle (Durso et al., 2010), swine (Rettedal et al., 2009; Thompson et 
al., 2008), and humans (Eckburg et al., 2005; Turnbaugh et al., 2009; Zoetendal et al., 
2001), which challenges the core microbiome hypothesis (Turnbaugh et al., 2007). 
Although CTC administration at the dose of 32 mg L-1 had no effect on the composition 
of the intestinal microbiota of mice in the current study, unexplainably the lowest dose of 
CTC (i.e. 2 mg L-1) affected the microbiota of the upper small intestine, whereas 8 mg L-1 
affected the microbiota of the large intestine. No residual CTC was detected in feces of 
mice given 2 mg L-1, so it remains to be elucidated whether lower doses of CTC 
differentially affect mucosa-associated communities in mice, or the inter-animal 
variability encountered obscured changes in the composition of the microbiota. 
In summary, the current study demonstrated that there was no substantive or 
consistent effects of AGP (i.e. CTC and sulfamethazine for cattle; CTC for mice) 
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administration on the microbiota of beef cattle intestines, nor on the composition of 
bacterial communities associated with the mucosa of the murine intestine. These findings 
are not consistent with the microbiota modulation being the main mechanism of AGP 
action in mammalian livestock. Thus, alternate mechanisms, including the involvement 
of host responses to AGP (Niewold, 2007), should be examined. 
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CHAPTER FIVE 
Non-therapeutic concentrations of orally administered chlortetracycline modulate 
immune responses to Citrobacter rodentium in mice 
 
ABSTRACT 
The development of efficacious alternatives to AGP in livestock production is an 
urgent issue, but is hampered by a lack of knowledge regarding the mode of action of 
AGP. The belief that AGP modulate the intestinal microbiota has become prominent in 
the literature; however, there is a lack of experimental evidence to support this 
hypothesis. Employing a Citrobacter rodentium-murine-CTC model, the ability of AGP 
to modulate the host immune system was investigated. Oral administration of non-
therapeutic doses of CTC regulated transcription levels of inflammatory cytokines in C. 
rodentium-infected mice, and minimized weight loss associated with infection. In 
addition, infected mice that received CTC presented with less pathologic changes in the 
distal colon than mice that did not receive CTC, relative to untreated mice. Furthermore, 
CTC administration did not impart profound or consistent effects on the colonic 
microbiota. The findings of this study supported the hypothesis that AGP function by 
modulating the host immune system. 
 
5.1 INTRODUCTION 
Animal production is an important segment of the global agricultural economy. The 
growing demand for high quality animal products has necessitated the development of 
means to enhance animal growth and thus optimize costs of production. An extensively 
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used method to promote growth of livestock and poultry is the in-feed administration of 
AGP, which are used at non-therapeutic concentrations. The use of AGP in animal 
production commenced more than 60 years ago (Moore et al., 1946). The benefits that 
AGP provide to animal performance and to the food production chain have resulted in 
their indiscriminate use in agriculture and animal production systems (Khachatourians, 
1998), and have contributed to the emergence of AMR in zoonotic pathogens (Conly, 
2002; Funk et al., 2006; Inglis et al., 2005). Many AGP, including tetracyclines, are used 
in human medicine for treatment of various infectious diseases (U.S senate bill S. 2508, 
2002). The potential for transmission of resistant bacteria from agricultural environments 
to humans have resulted in mounting societal concerns regarding AGP use 
(Khachatourians, 1998). From 1986 to 2006, the European Union implemented a ban on 
all AGP (Casewell et al., 2003; Castanon, 2007). The European AGP ban has resulted in 
a number of adverse consequences including a deterioration of animal health, an increase 
in the therapeutic administration of AMA (Casewell et al., 2003), an increase in the cost 
of animal production, and a general decline in livestock production (Jensen and Hayes, 
2003). The development of efficacious alternatives is an urgent matter, but is hampered 
by the current dearth of knowledge on the mode of action of AGP. It is clear that the 
sustainability of livestock production relies on the development of suitable and 
efficacious alternatives to AGP, and elucidating the mode of action of AGP will facilitate 
the development of biorationale-based alternatives.  
The literature on the mode of action of AGP is scarce, and the most accepted 
hypothesis is that AGP modulate the intestinal microbiota (Dibner and Richards, 2005; 
Gaskins et al., 2002). The “microbiota modulation” hypothesis suggests that AGP 
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reduces microbial competition for nutrients, results in fewer growth-depressing 
metabolites produced by microbial agents, suppresses opportunistic pathogens, results in 
a thinner intestinal wall, and thereby increases nutrient assimilation (Dibner and 
Richards, 2005). The absence of growth-promoting effects by AGP in germ-free animals 
(Coates et al., 1963) has been used as additional support for the microbiota modulation 
hypothesis. Despite general acceptance of this hypothesis, there has been no 
comprehensive assessment that definitively indicates that the administration of AMA in 
growth-promoting doses imparts substantive modification of intestinal microbiota.  
The consistency of growth-promoting effects of AGP on different animals 
possessing highly dissimilar intestinal microbiota compositions, and that AGP are 
typically administered at doses that are lower than the minimum inhibitory concentration 
for most pathogens, challenges the microbiota modulation hypothesis of AGP action 
(Niewold, 2007). Since many AMA have anti-inflammatory and immunomodulatory 
properties (Rubin and Tamaoki, 2005), an alternate hypothesis for the mode of action of 
AGP was recently proposed (Niewold, 2007). This alternate hypothesis indicates that 
AGP decrease the immunologic stress in the host (Klasing and Korver, 1997). The 
intestinal mucosa is in a constant state of “physiologic inflammation” (Ma et al., 2003), 
which is attributable to the close contact of the intestinal mucosa with the microbiota 
(Biancone et al., 2002). A decrease in the immunologic stress in intestinal mucosa by 
AGP would reduce the catabolic cost to the host and result in more energy available for 
muscle development, thereby improving growth performance (Roura et al., 1992). The 
“immunomodulation hypothesis” for AGP action is consistent with the growth-promotion 
effects observed when AGP is administered to animals possessing very dissimilar 
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intestinal microbiota compositions (Niewold, 2007). To my knowledge, the validity of 
the immunomodulation hypothesis has not been experimentally addressed. 
Citrobacter rodentium is a non-invasive, attaching/effacing bacterial pathogen that 
causes a self-limiting acute colitis in immunocompetent laboratory mice (Barthold et al., 
1978; Mundy et al., 2005), and has been widely accepted as a robust in vivo model 
system to assess host-pathogen interactions (Borenshtein et al., 2008; Mundy et al., 
2005). C. rodentium colonizes the apical surface of the large intestinal mucosa, causing 
mucosal hyperplasia, localized microvilli loss, and mucosal inflammation (Luperchio and 
Schauer, 2001), and was used in the present study as an inflammation inciter. 
The primary objective of the current study was to test the hypothesis that orally 
administered non-therapeutic doses of CTC modulate intestinal inflammatory responses 
in mice infected with C. rodentium. The effects of CTC, C. rodentium infection, and their 
interaction, on the composition of the murine intestinal microbiota were also assessed by 
T-RFLP analysis. To our knowledge, this is the first study to assess a potential interaction 
of AGP with the host immune responses concomitantly with potential AGP effects in the 
intestinal microbiota composition. This study furthers our understanding of the 
mechanisms of action of growth promotion by AGP, and will facilitate the development 
of efficacious alternatives.  
 
5.2 MATERIALS AND METHODS 
Mice and treatments 
Forty eight female 4-week-old C57BL/6J SPF mice were purchased from Charles 
River Laboratories International, Inc. (Montreal, QC). Mice were housed at the small 
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animal facility located at AAFC LRC. All requirements specified by the CCAC were 
met, and the project was approved by the LRC ACC before commencement of the study 
(Animal Use Protocol Review 0915). Mice were housed in sterilized, filter-topped cages 
throughout the experiment, with light cycle specified as in Chapter 4. Mice were 
randomly assigned to one of the following treatments: (i) no CTC, no inoculation 
(Control treatment); (ii) 32 mg L-1 CTC, no inoculation (CTC treatment); (iii) 32 mg L-1 
CTC, C. rodentium inoculation (CTC+CR treatment); and (iv) no CTC, C. rodentium 
inoculation (CR treatment). The 32 mg L-1 CTC was derived from the non-therapeutic 
dose of CTC administered to mammalian livestock (i.e. cattle; Chapter 4). Administration 
of CTC to mice commenced 3 weeks before inoculation with C. rodentium, and 
continued for the remainder of the experimental period. CTC was added to autoclaved 
drinking water, and fresh solutions were provided twice a week. Control and CR 
treatment mice were provided with autoclaved water alone. Sucrose (5% w/v; Sigma, St. 
Louis, MO) was added to all water solutions to enhance palatability, and water bottles 
were covered with aluminum foil.  
Citrobacter rodentium 
C. rodentium (ATCC 51459) was transformed with a gene that confers resistance to 
tetracycline. Plasmid pMEK91, a Campylobacter shuttle vector that carries the tetO gene 
(Mixter et al., 2003), was modified to remove the green fluorescent protein gene through 
EcoRI digestion and re-ligation. This vector was transferred into C. rodentium by 
electroporation using a protocol described previously (Shuli et al., 2007). Briefly, Luria-
Bertani (LB) broth (10 mL; BD, Franklin Lakes, NJ) was inoculated with an overnight 
culture of C. rodentium (5% v/v) and incubated for 2 h at 37 oC and 100 rpm. Cells were 
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harvested by centrifugation at 7000 x g for 2 min, and washed twice with ice-cold sterile 
optima water. Cells were suspended in 100 µL of ice-cold 10% glycerol, and an 80 µL 
aliquot was mixed with 10 µL of plasmid DNA, loaded in a 1 mm gap electroporation 
cuvette (Fisher Scientific Inc., Edmonton, AB), and incubated on ice for 20 min. 
Electroporation was performed with a model 2510 (Eppendorf Canada Ltd., Toronto, 
ON) at a pulse of 1.5 kV, followed by the immediate addition of Super Optimal broth 
with Catabolite repression (SOC; 1 M glucose, 2 M magnesium chloride, 2 M 
magnesium sulphate and 1 M potassium chloride in 10 mL LB broth). The electroporated 
cells were incubated for 1 h at 37 oC and 100 rpm, plated on LB agar dishes containing 
50 µg mL-1 tetracycline hydrochloride (Sigma, St. Louis, MO), and incubated overnight 
at 37 oC. To confirm resistance to tetracycline in the transformed strain, a minimum 
inhibitory concentration test was performed as previously described for tetracycline 
hydrochloride (Inglis et al., 2005); Escherichia coli (ATCC 25922) was used as the 
quality control strain. To test the growth abilities of the transformed strain, and to 
determine the optimal growth time to prepare inocula, a 24 h growth curve was produced 
for the transformed C. rodentium, and compared to a growth curve produced for the wild-
type C. rodentium (Appendix three). To prepare the growth curve, an overnight culture of 
C. rodentium (LB broth, 37 oC, 100 rpm) was added to LB broth (5% v/v) and incubated 
at 37 oC and 100 rpm. Culture samples were collected for optical density determination 
and C. rodentium enumeration every 2 h for the first 12 h, and at 24 h. For each time 
point, 100 µL of C. rodentium culture was spread onto MacConkey agar, incubated at   
37 oC, and enumerated at the dilution yielding 30-300 colony-forming units (CFU) dish-1. 
The transformed C. rodentium was cultured in LB broth with 50 µg mL-1 of tetracycline.  
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Inoculation and maintenance of mice 
To prepare inocula, transformed C. rodentium cells were cultured in LB broth 
containing 50 µg mL-1 of tetracycline for 16 h at 37 oC and 100 rpm, centrifuged for 5 
min at 1600 x g, the supernatant removed, and the pelleted cells resuspended in sterile 
phosphate buffer saline (PBS; 10 mM sodium phosphate buffer, 130 mM sodium 
chloride; pH 7.2) to a final concentration of 109 CFU mL-1. Sodium bicarbonate (2% w/v) 
was added to the inoculum. Mice (CR and CR+CTC treatments) were inoculated with 
100 µL (108 CFU) of the inoculum by oral gavage on two consecutive days. Uninoculated 
mice (Control and CTC treatments) were orally gavaged with an equal volume of PBS 
containing 2% sodium bicarbonate on the same days. Mice were provided with food and 
water ad libitum, and were weighed twice a week. In addition, mice were monitored for 
signs of disease according to the ACC criteria for stress assessment. 
Collection of feces and tissues  
Feces were collected aseptically from all mice once a week for estimating residual 
CTC, and every second day commencing 1 day after the initial gavage inoculation for 
enumeration of C. rodentium. Mice were humanely euthanized by anesthesia with 
isofluorane (Halocarbon Products Corporation, River Edge, NJ) followed by cervical 
dislocation 3, 8, 14, and 21 days post-inoculation (p.i), corresponding to early, peak, late 
infection, and clearance period, respectively (Mundy et al., 2005). Twelve mice were 
euthanized at each time point (i.e. three mice per treatment; n=48 total). After euthanasia, 
a midline incision was made, and the entire colon was rapidly harvested and examined 
for alterations in macroscopic appearance (i.e. thickening of the distal colon; Higgins et 
al., 1999). Four 1-cm sections from the colon were then collected (distal to cranial) for 
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histology, quantification of cytokine mRNA expression, characterization of colonic 
microbiota (i.e. using T-RFLP analysis), and C. rodentium enumeration, respectively. 
Colon samples collected for histology were preserved in 10% buffered formalin. Samples 
collected for RNA extraction were inserted in sterile microcentrifuge tubes containing 
RNAlater (Qiagen Inc., Mississauga, ON) and kept at -20 oC until processed; tissues were 
placed in RNAlater within 2-3 min of euthanasia. For T-RFLP analysis, the colon was 
cut-open longitudinally, the mucosal surface was gently rinsed with chilled sterile PBS, a 
tissue sample was aseptically removed with a sterile 3-mm-diameter Biopsy Acu-Punch 
(CDMV, St. Hyacinthe, QC), and the sample was placed at -20 oC until processed. 
Colonic samples collected for enumeration of C. rodentium were placed on ice 
immediately after collection, and processed within 2 h.   
Estimation of residual CTC in murine feces 
Residual CTC in murine feces was measured as described previously in Chapter 4 
with the following modification. The diameters of the inhibition zones were measured 
using a Biomic V3 Image Analyzer (Giles Scientific USA, Santa Barbara, CA), with 
slight adjustments performed by hand. 
Enumeration of C. rodentium  
Densities of C. rodentium cells were determined by homogenizing feces or colonic 
samples in Columbia broth, and spreading serial dilutions of the homogenate onto 
MacConkey agar (BD). Incubation of cultures and enumeration of colonies were 
performed as described above. C. rodentium colonies were identified based on 
morphology (Vallance et al., 2002), and representative colonies exhibiting characteristic 
morphology (i.e. an average of three colonies per Petri dish) were subcultured to confirm 
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their identity and the presence of the tetO gene by PCR. Reaction mixtures for PCR 
consisted of 2 µL of a suspension of cells in 20 µL of optima water, 1X PCR buffer, 0.2 
mM of each deoxynucleoside triphosphate, 0.1 μg μL-1 of acetylated bovine serum 
albumin (Promega, Madison, WI), 0.625 U of Taq DNA polymerase (Qiagen Inc.), 0.5 
μM of each primer, and optima water to a final volume of 20 μL. For C. rodentium 
identification, the Cr-espB-f (5′-AAGTCTGTCAATACCGCCTC-3′) and Cr-espB-r (5′-
AATGTGCCAACTGTCTCATC-3′) primers were used (Maaser et al., 2004). For tetO 
gene detection, the tetO-F-PstI (5′-TAA CTG CAG AGA TTC AGT ATT ATA ACA 
AGG-3′), and tetO-R-PstI (5′-TTA CTG CAG CAT CAT AAT TAT CTC TAA TCC-3′) 
primers were used (Mixter et al., 2003). 
Histopathology  
Tissue samples were maintained in 10% buffered formalin for a minimum of 4 h 
and for a maximum of 2 weeks. Tissue samples were dehydrated with ethanol and 
Histoclear (Fisher Scientific Inc.), and paraffinized with Paraplast Plus (Fisher Scientific 
Inc.) for 2 h at 60 oC in a vacuum oven. Samples were embedded using a Shandon 
Histocentre III (Fisher Scientific Inc.), sectioned (4 µm) using a Finesse 325 microtome 
(Fisher Scientific Inc.), and sections were placed on Superfrost Plus Gold slides (Fisher 
Scientific Inc.). Sections were deparaffinized with xylene, stained with hematoxylin and 
eosin (H&E) following a standard protocol, and examined with a Zeiss Axioskop III 
(Carl Zeiss Canada Ltd., Toronto, ON). Images were captured using an Axiocam camera 
(Carl Zeiss Canada Ltd.). Histological inflammation scoring was performed in a 
“blinded” fashion (i.e. as to treatment) by a Veterinary Pathologist (Dr. Richard R. E. 
Uwiera, University of Alberta), with scoring criteria adapted from previously described 
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methods (Barthold et al., 1978; Wu et al., 2008) as shown in Table 5.1. The total 
pathology score was obtained by calculating the sum of scores for all categories for each 
mouse. Epithelial hyperplasia caused by C. rodentium (i.e. crypt height) was quantified 
by calculating the average of 10 measurements of well-oriented crypts for each section. 
Quantification of mRNA expression of cytokine genes  
Total RNA was extracted from mouse colonic tissues with TRIzol reagent 
(Invitrogen Corp., Carlsbad, CA) according to the manufacturer’s recommendations. 
Residual genomic DNA contamination was removed using a DNA purification protocol 
from RNeasy kit (Qiagen Inc.). After quantification on an Ultrospect 3100 pro 
UV/Visible spectrophotometer (General Electric Healthcare, Piscataway, NJ), 1 µg of 
total RNA was reverse transcribed into cDNA using the RT2 First Strand Kit 
(SABiosciences Corp., Frederick, MD). Quality assurance and control of total RNA was 
performed with the RT2 RNA QC PCR Arrays Kit. A custom RT2 Profiler PCR Array 
System (SABiosciences Corp.) was used to quantify the mRNA expression of the 
following cytokines: interleukin (IL)-1β, IL-2, tumor necrosis factor (TNF)-α, interferon 
(IFN)-γ, IL-6, IL-4, IL-10, IL-17A, IL-22, and transforming growth factor (TGF)-β1. 
Two housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
actin-β were used to provide an estimate of the range of threshold cycles to be expected 
in subsequent PCR array analyses. The housekeeping gene that presented the least 
variation of expression among samples with the quality control kit was used to normalize 
the data. Real-time PCR was performed using an MxPro 3005 thermocycler (Agilent 
Technologies, Santa Clara, CA). To prepare cytokine mRNA expression data for the 
comparative cross-threshold (Ct) method and ANOVA, Ct values of the 10 cytokine  
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genes of interest were normalized with GAPDH transcript data (i.e. GAPDH transcript 
levels, which presented less variation in expression than the β-actin in the quality 
assurance analysis). Normalized data (Ct values) were then inserted as an exponential 
function of two, to account for the fold change of amplicons at each PCR cycle. In order 
to apply the experimental design to the mRNA expression data and to include control 
values in the analysis, Ct values were normalized only with the housekeeping gene and 
not with the Control Ct values. All cytokine mRNA expression data was adjusted and 
log-transformed (i.e. log [2-Ct + 1]) before statistical analysis.  
Characterization of bacterial communities  
Total genomic DNA was extracted from colonic samples using the Gram-positive 
bacteria protocol of the DNeasy Blood and Tissue Kit (Qiagen Inc.). Amplification of the 
16S rRNA genes for T-RFLP analysis, restriction of amplified rRNA genes, capillary gel 
electrophoresis, fragment size determination, and analyses were conducted as described 
previously in Chapter 4. 
 Statistical Analyses 
The experiment was designed as a randomized complete block design with (i) two 
levels of treatment (i.e. CTC or no CTC, and C. rodentium or no C. rodentium); (ii) four 
(i.e. for C. rodentium CFU associated with colonic mucosa, cytokine mRNA expression, 
and colonic crypt height), six (i.e. for murine body weights), or eleven (i.e. for C. 
rodentium CFU in murine feces) levels of time; and (iii) three levels of block as the three 
replicates were conducted on separate occasions and thus were independent. Data 
analyses of T-RFLP data were performed as described in Chapter 4. All data were 
analyzed using SAS software (SAS Institute Inc., Cary, NC). For parametric data (i.e. 
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CFU counts in feces and colon, murine weight, and cytokine mRNA expression), 
ANOVA was performed using the MIXED procedure of SAS, with treatment one (i.e. 
CTC or no CTC), treatment two (i.e. C. rodentium or no C. rodentium), time, and their 
interaction, included in the model as fixed effects. Differences among means of interest 
were compared through the generation of least-square means with Fisher’s protected least 
significant difference test. For C. rodentium CFU counts in feces and murine body 
weights, the repeated-measurement statement was applied, and the proper error structure 
was determined using Akaike’s information criterion and the Bayesian information 
criterion. In all instances, the UNIVARIATE procedure of SAS was used to produce 
normal probability plots to confirm normality and to identify outliers, which were 
removed before completion of the final analysis. For non-parametric data (i.e. 
histological inflammation scoring data for individual category scores and total scores), 
the NPAR1WAY procedure of SAS with the Wilcoxon scores (ranks sums) for variable 
score and one-sided Wilcoxon two-sample test were performed. 
 
5.3 RESULTS 
Residual CTC in murine feces 
Residual CTC was detected in acidic extracts of feces from mice administered 
CTC, and no difference was observed between the CTC and CTC+CR treatments 
(P0.05). Mean residual CTC value was 63.9  6.6 µg g-1 of feces for CTC treatment 
mice, and 63.3  9.6 µg g-1 of feces for CTC+CR treatment mice. No evidence of CTC 
was observed in acidic extracts prepared from feces of mice that were not administered 
CTC. 
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Administration of CTC did not affect C. rodentium colonization 
Considerable numbers of C. rodentium cells were recovered from feces and colonic 
mucosa of inoculated mice throughout the experiment (Figure 5.1). No C. rodentium cells 
were recovered from uninoculated mice. Densities of C. rodentium cells recovered from  
feces and mucosal surfaces increased over time (P0.001); population sizes peaked 
between 9 and 11 days p.i., and decreased thereafter until no cells were detected 21 days 
p.i. (Figure 5.1). Relative to the CR treatment, the administration of CTC did not affect 
(P=0.81) densities of C. rodentium CFU in murine feces (P=0.84) at all sample times 
(Figure 5.1, A). With the exception of the 3 day p.i. sample time (P<0.05), there was also 
no difference (P0.05) between treatments in densities of C. rodentium CFU associated 
with colonic mucosa (Figure 5.1, B).  
Stability of plasmid containing the tetO gene in transformed C. rodentium 
All C. rodentium cells recovered and evaluated from the feces of CTC+CR 
treatment mice possessed the tetO gene until day 19 p.i., but did not present the plasmid 
at day 21 p.i. All C. rodentium cells recovered and evaluated from CR treatment mice  
possessed the tetO gene until day 9 p.i.; 50% of cells possessed the tetO gene at days 11 
and 13 p.i., and no cells possessed the tetO gene at days 15, 17, 19, and 21 p.i. 
Administration of CTC prevented C. rodentium-induced weight loss 
Mice infected with C. rodentium (i.e. CR treatment and CTC+CR treatment) did 
not present ante mortem signs of disease. However, CR treatment mice weighed less 
(P0.05) than Control treatment mice on days 7, 10, and 14 p.i. (Figure 5.2). Mice 
infected with C. rodentium and administered CTC (i.e. CTC+CR treatment) weighed less 
(P0.05) than Control mice only on day 10 p.i., and weighed more (P0.05) than CR  
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Figure 5.1. Quantities of C. rodentium cells in feces (A) and associated with colonic 
mucosa (B). Vertical lines indicate standard error of the means (n=3). * Values differ 
(P0.05).  
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Figure 5.2. Change in body weight. Vertical bars associated with means indicate the 
standard error of the mean. * P<0.05 when compared with Control mice; ** P<0.05 
when compared with Control or CTC treatment mice; *** P<0.05 when compared with 
Control, CTC or CTC+CR treatment mice.  
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treatment mice on day 14 p.i. There was no difference (P>0.05) in body weight between 
the Control and CTC treatment mice. 
Administration of CTC decreased pathologic changes caused by C. rodentium 
Gross observations indicated thickening of the distal colon of approximately two 
thirds of CR and CTC+CR treatment mice at day 8 p.i. Conspicuous thickening of the  
distal colon was evident 14 days p.i. in all CR treatment mice and approximately two 
thirds of CTC+CR treatment mice (Figure 5.3). Histopathological analysis of colonic 
cross-sections revealed that all C. rodentium-infected mice (i.e. CR and CTC+CR 
treatments) had pathologic changes relative to Control mice (Table 5.2, Figure 5.4). 
Levels of inflammation increased throughout the infection period, with the highest scores 
of inflammation observed 14 days p.i. Notably, transmural inflammation and eosinophilic 
bacterial colonies were observed only in the colons of CR treatment mice at day 14 p.i. 
(Figure 5.4). Infection by C. rodentium increased (P<0.05) crypt height, which was first 
evident 8 days p.i., and crypt height remained significantly different relative to the 
Control and CTC treatment mice throughout the remainder of the experimental period 
(Figure 5.5). Crypt height reached a maximum 14 days p.i. (P<0.05, Figure 5.5). There 
was no difference (P>0.05) in crypt height between the CTC+CR and CR treatments, or 
between the Control and CTC treatments. Total pathology scores and individual category 
scores representing tissue changes did not differ (P0.05) between treatments at day 3 p.i. 
(Table 5.2). At subsequent sample times there was no difference (P>0.05) between 
Control and CTC treatments, nor between CTC+CR and CR treatments. At day 8 p.i., 
total score and all individual category scores differed (P0.05) for the CTC+CR and CR 
treatments relative to the Control treatment. Although there was no significant difference  
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Figure 5.3. Gross pathology of the murine large intestine (cecum to rectum). No 
difference in thickness of the descending colon was observed between Control (A) and 
CTC (B) treatment mice. All C. rodentium-infected mice (D) had conspicuous thickening 
of the distal colon (arrow), which was not observed in all infected mice that received 
CTC (C). Horizontal bar corresponds to 1 cm. 
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Figure 5.4. Microphotographs (H&E stained cross sections, original magnification 10X) 
of the murine distal colon. Colonic sections of Control (A) and CTC (B) treatment mice 
had no pathologic changes. In contrast, colons of CTC+CR (C) and CR (D) treatment 
mice had submucosal inflammation (arrows) and hyperplasia, particularly 8 and 14 days 
p.i. Bars indicate 100 µm. 
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Figure 5.5. Epithelial crypt height. Vertical lines associated with histograms are standard 
error of the means (n=3). Bars not indicated with the same letter differ significantly 
(P<0.05). 
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between CTC+CR and CR treatments, there was a trend for decreased pathologic changes 
in CTC+CR treatment at later stages of infection. For example, there was no difference 
(P>0.05) in mitotic activity scores for the CTC+CR relative to the Control treatment at 14 
days p.i., whereas mitotic activity was higher (P<0.05) for the CR treatment relative to 
the Control treatment (Table 5.2). At day 21 p.i., crypt height, inflammatory infiltrates, 
and total pathology scores differed (P<0.05) between the Control and CR treatments but 
did not differ (P>0.05) between the Control and CTC+CR treatments. 
C. rodentium infection differentially regulated mRNA expression of cytokines 
To assess murine immune responses to C. rodentium, mRNA expression of Th1- 
(IFN-γ, TNF-α, and IL-2), Th2- (IL-4), Treg- (IL-10 and TGF-β1), and Th17- (IL-17A, 
IL-22, IL-1β, and IL-6) related cytokines in colonic tissues was quantified by RT-qPCR 
at various stages of infection. C. rodentium infection resulted in higher (P<0.05) 
expression of cytokine mRNA associated with the Th1 (Figure 5.6, A and B) and Th17 
(Figure 5.6, D, E, F and G) pathways 8 and 14 days p.i. Transcript levels of IL-2 were 
differentially elevated (P<0.05) in infected mice at 21 days p.i. only. No significant 
changes in transcript levels of cytokine genes associated with the Th2 (Figure 5.6, H), 
and Treg (Figure 5.6, I, J) pathways were observed in infected mice. Mice from the CTC 
treatment did not show differential mRNA expression for most cytokines relative to the 
Control treatment. However, a decrease (P<0.05) in the expression of TGF-β mRNA and 
an increase (P<0.05) in expression of IL-4 mRNA were observed in CTC treatment mice 
on day 21 p.i.   
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Figure 5.6. Relative mRNA expression (log [2-Ct + 1]) of cytokines in colonic tissues. 
Vertical lines associated with histogram bars are standard error of the means (n=3). (A) 
IFN-γ; (B) TNF-α; (C) IL-2; (D) IL-17A; (E) IL-22; (F) IL-1β; (G) IL-6; (H) IL-4; (I) IL-
10; (J) TGF-β. Bars not indicated with the same letter differ significantly (P<0.05). 
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Administration of CTC modulated murine immune responses to C. rodentium 
In infected mice, CTC administration (i.e. CTC+CR treatment) increased (P<0.05) 
transcript levels of IFN-γ, TNF-α, IL-2 and IL-22 genes (Figure 5.6, A, B, C, E) and 
decreased (P<0.05) transcript levels of the IL-1β gene 8 days p.i relative to the CR 
treatment (Figure 5.6, F). Furthermore, administration of CTC to infected mice decreased 
(P<0.05) transcript levels of the IFN-γ, TNF-α, IL-17A, IL-22, and IL-1β genes 14 days 
p.i. relative to the CR treatment (Figure 5.6, A, B, D, E, F).  
Temporal treatment effects (i.e. C. rodentium inoculation and/or CTC 
administration) on cytokine mRNA expression are further illustrated in Figure 5.7. 
Transcript levels of IFN-γ and TNF-α progressively increased over time, with the highest 
expression observed at day 14 p.i., whereas transcript levels of IL-22 and IL-1β (Th17-
related cytokines) peaked at day 8 p.i., and decreased at day 14 p.i. For Th17 cytokines, a 
trend was observed for an initial increase in transcript levels of IL-17A, IL-22, and IL-6 
genes in infected mice administered CTC relative to CR treatment mice. At day 14 p.i., 
transcript levels of these cytokine genes in CTC+CR treatment mice tended to decrease 
differentially relative to CR treatment mice. Transcript levels of IL-1β in CTC+CR mice 
remained lower relative to CR treatment mice at both the peak and late infection periods. 
Colonic microbiota was not consistently affected by C. rodentium or CTC treatment 
Diverse bacterial communities were observed in association with mucosal surfaces 
of the colon of all mice regardless of treatment. Global and pairwise comparisons using 
the group significance test performed on T-RFLP relative abundance and 
presence/absence data indicated a high level of inter-animal variability (Figure 5.8). 
Ordination of T-RFLP profiles by NMS analysis revealed no obvious grouping of 
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Figure 5.7. Temporal transcript levels of cytokine mRNA in the distal colon of treatment 
mice. Cytokines are grouped by type of Th response.  
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Figure 5.8. Non-metric multi-dimensional scaling applied to presence/absence T-RFLP 
profiles of mucosa-associated bacterial communities in the murine distal colon at days 3 
(A), 8 (B), 14 (C), and 21 (D) p.i., showing no treatments effects over time. () Control 
treatment; () CTC treatment; () CTC+CR treatment; and () CR treatment. Each 
data point corresponds to an individual sample. Inter-animal variability is illustrated by 
the dispersion of data points from the same treatment.  
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replicate mice within treatments at individual sample times p.i. (Figure 5.8). Global 
comparisons using the group significance test revealed the formation of unique (P0.05) 
community compositions for the Control and CTC+CR treatments at 8 days p.i., and for 
the CTC+CR and CR treatments at 21 days p.i. (Table 5.3). However, pairwise 
comparisons indicated that the composition of the colonic microbiota was not 
consistently affected by CTC or CR treatments over time (Table 5.3). However, when 
data from all time points were examined collectively, there was a subtle but significant 
difference in the composition of the between CTC-treated mice and those that did not 
receive CTC (Figure 5.9). Conversely, there was no difference in the composition of the 
colonic microbiota between Control and CR treatment mice (Figure 5.9). In summary, 
infection with C. rodentium did not affect (P0.05) the composition of the colonic 
microbiota, whereas administration of CTC caused subtle and inconsistent changes in the 
colonic microbiota (Table 5.3, Figure 5.8). 
 
5.4 DISCUSSION 
 Research examining the use of AGP in agriculture and animal production have 
predominantly focused on measuring the prevalence of AMR in human pathogens 
(Alexander et al., 2008; Berge et al., 2006; Funk et al., 2006; Ghosh and LaPara, 2007; 
Inglis et al., 2005; Langlois et al., 1978). Modulation of the microbiota by AGP is 
putatively thought to be the primary mode of action of AGP (Dibner and Richards, 2005; 
Visek, 1978). However, there is a deficiency of experimental evidence to support this 
hypothesis. The current study tested the hypothesis that AGP promote growth through an 
interaction with the immune system of the host. It is noteworthy that CTC administration  
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Figure 5.9. Non-metric multi-dimensional scaling applied to presence/absence (A) and 
relative abundance (B) of T-RFLP profiles of mucosa-associated bacterial communities 
in the murine distal colon. () Control treatment; () CR treatment; () CTC treatment 
() CTC+CR treatment; and. Closed-line clusters in A and B are composed 
predominantly of CTC-treated mice. Dashed-line clusters in A and B are composed 
predominantly of mice that did not receive CTC.  
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modulated C. rodentium-induced cytokine mRNA expression, prevented C. rodentium-
induced weight loss, and mitigated pathologic changes associated with infection. These 
findings support the immunomodulation hypothesis of AGP action. 
Cell mediated and humoral immunity are required for pathogen clearance in C. 
rodentium infection (Simmons et al., 2003). The T cell compartment of the immune 
system can respond to an enormous variety of antigens (Romagnani, 2006), and the type 
of immune response will depend on the differentiation of effector CD4+ T (helper) cells, 
which are defined according to their pattern of cytokine secretion (Mosmann et al., 
1986). In the current study, C. rodentium infection up-regulated Th1 and Th17-related 
cytokine mRNA expression at the peak (day 8 p.i.) and late (day 14 p.i.) stages of 
infection, which is in accordance with previous reports (Higgins et al., 1999; Symonds et 
al., 2009). C. rodentium also induced histopathologic changes that were concomitant with 
cytokine expression patterns. C. rodentium initially colonizes the cecum, and 
colonization eventually extends to the distal colon (Wiles et al., 2004) where the 
bacterium incites acute, self-limited colitis associated with progressive crypt hyperplasia 
(Barthold et al., 1978). Thickening of the distal colon observed here was attributed 
primarily to mucosal hyperplasia induced by C. rodentium (Higgins et al., 1999). Severe 
colitis as observed in C. rodentium-infected mice can also be attributed to transmural 
inflammation and infiltration of inflammatory cells to the submucosa, muscularis externa, 
and serosa (Dann et al., 2008; Luperchio and Schauer, 2001). 
All infected mice exhibited temporal up-regulation of mRNA expression of Th17-
related cytokines that peaked at day 8 p.i. In contrast, mRNA expression of IL-17A and 
IL-6 peaked at 14 days p.i. in infected mice that did not receive CTC. It is noteworthy 
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that in infected mice administered CTC, the transcript levels of IL-17A, IL-22, and IL-6 
genes decreased relative to CR treatment mice at late infection. The Th17 subset of cells 
were shown to play a crucial role in induction of autoimmune diseases (Kolls and Lindén, 
2004), as well as in clearance of extracellular bacterial pathogens that are not adequately 
handled by Th1 or Th2 responses (Korn et al., 2009; Weaver et al., 2007). C. rodentium 
is known to induce a strong Th17 response (Korn et al., 2009; Symonds et al., 2009; 
Zheng et al., 2008), which is mediated largely by IL-22 (Zheng et al., 2008). 
Nonetheless, clearance of C. rodentium by Th17 differentiation is dependent on an 
extensive inflammatory tissue response, which is mediated primarily by the pro-
inflammatory cytokine IL-17A (Korn et al., 2009). Here, the observed progressive 
hyperplasia in infected mice may be attributed primarily to the early differentiation of the 
Th17 subset of cells. It was observed that the expression of IL-17A was reduced at late 
infection in C. rodentium-infected mice that received CTC, which may be attributable to 
the reduced pathologic changes observed in the distal colon of mice from this treatment 
group. Furthermore, mRNA expression of IL-22 in infected mice that received CTC was 
down-regulated at the late stage of infection, and up-regulated at the peak stage of 
infection. IL-22 is crucial in innate immunity against C. rodentium, is required in the 
early host response, maintains colonic epithelial integrity, and induces production of the 
Reg family of antimicrobial proteins (Zheng et al., 2008). Therefore, modulation of IL-22 
transcript levels by CTC administration observed in the current study would be expected 
to contribute to pathogen clearance as well as decreased epithelial injury.  
It has been shown that TGF-β has a critical role in the commitment of the Th17 
lineage of cells in the presence of IL-6 (Korn et al., 2009; Mangan et al., 2006). 
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However, it was recently reported that Treg efficiently inhibited the proliferation of 
effector Th17 cells and their production of the pro-inflammatory cytokines IL-22 and IL-
17A, as well as the chemokine CXCL8 (Crome et al., 2010). Therefore, the progressive 
increase in TGF-β expression that was observed over time may be correlated to the 
decrease of Th17-related cytokines in mice at the late stage of infection and at clearance 
(i.e. day 21 p.i.). IL-6 induces the development of Th17 cells from naïve cells together 
with TGF-β, but inhibited TGF-β-induced Treg differentiation (Kimura and Kishimoto, 
2010). This may explain the similar mRNA expression pattern between IL-6 and IL-17A, 
and the decreased transcript levels of TGF-β observed in early and peak stages of 
infection. 
Another interesting observation of the present study was that infected mice 
presented temporal up-regulation of mRNA expression of Th1-related cytokines, with the 
highest transcript levels of IFN-g and TNF-a occurring at the late stage of infection, and 
the highest transcript levels of IL-2 occurring at clearance, regardless of CTC 
administration. The fact that Th1 and Th2 responses are mutually regulated and 
antagonistic (Parronchi et al., 1992) explains how mRNA expression of IL-4 (i.e. Th2-
related cytokine) was not modulated in infected mice, which presented progressive up-
regulation of Th1-related cytokines. Nevertheless, mRNA expression of IL-4 was 
increasing by the clearance period in infected mice that received CTC, which can be 
attributed to the simultaneous decrease in mRNA expression of IFN-γ and TNF-α and the 
simultaneous increase in mRNA expression of IL-2. The decreased Th1 response at 
clearance might have contributed to initiate differentiation of Th2 cells, since naïve T-
cells can produce sufficient IL-2 and IL-4 to induce their differentiation into Th2 cells 
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(Ansel et al., 2006). Even so, uninoculated mice that received CTC presented higher 
concentrations of IL-4 on clearance period thus suggesting that CTC may be contributing 
directly to the differentiation of Th2 cells. Regarding the increase in mRNA expression of 
IL-2 at clearance only, it has been reported that C. rodentium lysates inhibited IL-2 by 
mitogen-stimulated lymphoid cells (Malstrom and James, 1998) which may exert critical 
functions in bacterial pathogenesis. Furthermore, IL-2 is known to inhibit differentiation 
of Th17 cells, and to promote generation of Treg cells, which might explain the 
concurrent increasing concentrations of TGF-β at clearance period. The mRNA 
expression of IL-10 (i.e. Treg-related cytokine), was not altered by C. rodentium 
infection in the current study, likely because IL-10 is not critical for protection against C. 
rodentium (Spahn et al., 2008). 
Although C. rodentium is a non-invasive bacterial pathogen, translocation of the 
bacterium into the lamina propria may occur through leaky tight junctions and damaged 
epithelium, thereby inducing a mucosal Th1 response (Higgins et al., 1999). Moreover, 
an increase in the production of keratinocyte growth factor occurs in response to 
proinflammatory cytokines in C. rodentium infection (Higgins et al., 1999), resulting in 
epithelial cell proliferation. The temporal up-regulation of Th1-related cytokines 
observed in the current study, with highest levels on late infection, is attributed to the 
progressive and concomitant mucosal hyperplasia and epithelial damage induced 
primarily by the early differentiation of Th17 cells. 
Infected mice that received CTC also presented lower mRNA expression of acute-
phase response cytokines at the late stage of infection, which may have contributed to 
pathogen clearance. Transcript levels of IL-1β were down-regulated at the peak and late 
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stages of infection, whereas those of TNF-α were up-regulated at early infection and 
down-regulated at the late stage of infection. An acute-phase response is triggered by an 
infectious challenge, and is characterized by the release of the pro-inflammatory 
cytokines IL-1β, IL-6, and TNF-α, which orchestrate behavioral, cellular, and metabolic 
adjustments that alter the partitioning of nutrients away from growth and toward 
processes that support the immune and inflammatory responses (Klasing and Korver, 
1997). Furthermore, IFN-γ, IL-1β and IL-6 facilitate TNF-α-induced muscle cachexia 
(Pajak et al., 2008). It has been reported that therapeutic administration of tetracycline 
orally reduced lethality and inflammatory lesions associated with lipopolysaccharide 
(LPS)-induced septic shock in mice by decreasing serum concentrations of TNF-, and 
have inhibited LPS-induced secretion of TNF- and IL-1β by human monocytes in vitro 
(Shapira et al., 1996). The non-therapeutic administration of tetracycline to 
experimentally stressed poultry has been shown to reduce immunologic stress by 
decreasing plasma concentrations of IL-1 (Roura et al., 1992). These researchers, 
however, did not attribute the decrease in plasma concentrations of IL-1 to a direct effect 
of tetracycline on monocytes, which was justified by a previous report indicating that this 
antimicrobial agent had no direct effect on IL-1 release by monocytes at non-toxic 
concentrations in vitro (Roche et al., 1988). Conversely, concentrations as low as 0.1 mg 
mL-1 CTC decreased TNF-α secretion by cultured swine Kupffer cells that were 
inoculated with LPS (Akunda et al., 2001). In addition, intra-peritoneal injection of 10 
mg kg-1 bw tetracycline, and as low as 1.5 mg kg-1 bw doxycycline decreased murine 
serum concentrations of IL-1α and TNF-α (Milano et al., 1997). In the current study, 
administration of CTC to infected mice was also observed to decrease the expression of 
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IL-17A at late infection, which may be attributable to the down-regulation of TNF-α and 
IL-1β mRNA at the late stage of infection. It has been reported that Th17 cell response is 
amplified by TNF-α and IL-1β (Veldhoen et al., 2006).  
Altogether, reduced pathological changes observed at the late stage of infection as 
well as at clearance, and the absence of weight loss at late infection in infected mice that 
received CTC is attributed to the up-regulation of IL-22 transcripts at the peak stage of 
infection, and the down-regulation of TNF-, IL-1β, and IL-17A transcript levels at the 
late stage of infection relative to infected mice not administered CTC. 
Infection by C. rodentium did not have a profound effect on the mucosa-associated 
microbiota of the murine distal colon in the current study. In contrast with these findings, 
partial 16S rRNA gene sequence analysis of mucosa-associated and luminal bacteria in 
mice infected with C. rodentium revealed alterations to the microbiota (Hoffmann et al., 
2009). However, they only examined communities in the cecum and proximal colon, and 
communities were resolved at the phylum level. Furthermore, no assessments of inter-
animal variability were performed (Hoffmann et al., 2009). One of the major advantages 
of T-RFLP is the ability to monitor treatment effects on the microbiota composition by 
comparing community profiles (Hartmann and Widmer, 2008), which also enables 
valuable assessments of inter-animal variability. The inter-animal variability observed in 
the current study may have obscured effects of C. rodentium infection on the colonic 
microbiota. Alternatively, C. rodentium may not exert substantive impacts on the 
microbiota given the bacterium does not colonize the distal colon during the entire 
infection period (Wiles et al., 2006). The presence of marked hypoxia within the lumen 
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of the distal colon (He et al., 1999) may partly explain why C. rodentium colonization 
initiates in the cecum (Wiles et al., 2004). 
Administration of CTC was observed to affect the composition of the colonic 
microbiota independent of C. rodentium infection in the present study. However, an 
effect on the microbiota was only detected when all time points were analyzed together. 
Thus, CTC exerted subtle effects on the colonic microbiota in the current study, which 
were inconsistent over time. Administration of non-therapeutic CTC substantially 
impacted the mucosa-associated microbiota of piglet’s ileums, (Rettedal et al., 2009). In 
contrast, a recent study reported that the administration of virginiamycin and tylosin to 
intensively raised swine at the grow/finishing phase had no effect on the community 
composition (Kalmokoff et al., 2010). These researchers also observed a high prevalence 
of bacteria that carried genes encoding resistance to macrolide-lincosamide-streptogramin 
B (MLSB), from which they explained the negative impact of AGP on the fecal 
community (Kalmokoff et al., 2010). Host genetics and environmental factors can both 
affect the intestinal microbiota. For example, the fecal microbiota of persons with gene 
mutations associated with the autoinflammatory disorder, familial Mediterranean fever, 
presented significant changes in composition, that were also observed at the remission 
period (Khachatryan et al., 2008). Also, Altered Schaedler Flora (ASF) mice of the same 
genetic background exhibit significant variation in the intestinal relative cell densities of 
the eight ASF strains when mice were maintained in separate cages (Alexander et al., 
2006).  
The inter-animal variability encountered in the current and previous studies 
(Alexander et al., 2006; Durso et al., 2010; Rettedal et al., 2009) further illustrates how 
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difficult it is to quantify the impact of a single variable in such a complex system. For 
example, Rumsey et al., (1999) demonstrated that non-therapeutic CTC reduced the 
sensitivity of the bovine pituitary gland to a releasing hormone challenge, which may 
promote improved energy efficiency of tissue deposition. This alternate hypothesis also 
emphasizes that the direct interaction of AGP with the microbiota is not the main 
mechanism of growth promotion, and that host responses should not be discounted in 
studying AGP action. 
Whereas CTC administration modulated immune responses in the colon in the 
current study, it was not possible to definitely conclude whether this effect was a direct or 
indirect effect of CTC. Considering a direct effect of CTC on the microbiota, it is unclear 
to how and to what degree subtle changes in the microbiota caused by CTC would induce 
growth promotion, especially given the complexity of the mechanisms involved and that 
AGP exert an effect in animals possessing a highly dissimilar microbiota. It has been 
shown that the indigenous microbiota can influence C. rodentium pathogenesis 
(Luperchio and Schauer, 2001), thus even subtle changes in the microbiota may have 
influenced immune responses to C. rodentium, further illustrating the complexity of the 
interaction and the difficulty of elucidating specific effects.  
In conclusion, the mucosa-associated microbiota of the murine colon was not 
affected by C. rodentium, and was inconsistently affected by oral administration of non-
therapeutic CTC in the current study. Furthermore, non-therapeutic CTC administration 
modulated immune responses to C. rodentium infection in mice. Although subtle and 
inconsistent, CTC administration did alter the composition of the colonic microbiota. 
Thus, it was not possible to definitively ascertain whether CTC directly or indirectly 
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modulated the immune system. Nonetheless, that non-therapeutically administered AGP 
directly or indirectly modulate the intestinal immune system indicates that modulation of 
the microbiota alone is not responsible for growth promotion. The research presented in 
this Chapter not only broadens our knowledge of how AGP exert an effect, it also 
emphasizes the necessity of examining host responses interactively with the intestinal 
microbiota in future studies to elucidate the mechanisms of action of AGP.   
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CHAPTER SIX 
General discussion and future directions 
 
6.1 Characterization of intestinal microbial communities 
Elucidating interactions among the host, environmental factors, and microbiota in 
the mammalian GI tract is remarkably challenging, due to the complexity of this 
ecosystem. Advances in molecular biology have facilitated the acquisition of new 
knowledge regarding the structure and function of GI microbiota. Techniques such as T-
RFLP allow analyses of numerous samples, making it possible to document spatial and 
temporal changes in microbial communities with high efficiency (Hartmann and Widmer, 
2008). One of the salient advantages of T-RFLP analysis is its utility in empirical studies 
to evaluate treatment effects on the composition of the microbiota. Nevertheless, T-RFLP 
has limitations for accurate determination of microbial diversity in highly complex 
ecosystems (Engebretson and Moyer, 2003), as well as in species identification within 
communities (Pandey et al., 2007). It is noteworthy that T-RFLP profiles can be used to 
choose appropriate samples for clone library analysis, and T-RFs can be identified by 
comparison to clone sequences. In that regard, combining T-RFLP and clone library 
analysis substantially increases the probability of accurately identifying a particular 
bacterial species, while retaining the high-throughput advantages of T-RFLP 
(Moeseneder et al., 2001).  
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6.2 Variation in intestinal microbiota composition among individuals  
Another challenge frequently faced in characterizing temporal and spatial 
assessments of the mammalian microbiota is the high level of inter-individual variability. 
The results of recent studies (16S rRNA gene sequencing) characterizing human fecal 
microbiota now question the existence of a core intestinal microbiota in humans (i.e. 
commonality amongst individuals; e.g. Turnbaugh et al., 2007). Similarly, recent 
research in cattle revealed remarkable variation in the fecal microbiota among individuals 
(Durso et al., 2010), and 16S rRNA gene sequencing of mucosa-associated bacteria from 
swine also indicated substantial inter-animal variability (Funk et al., 2006). Furthermore, 
the composition of bacterial communities associated with the intestinal mucosa varies 
greatly from that present in the digesta and feces (Eckburg et al., 2005; Zoetendal et al., 
2002), which suggests that fecal communities may not be representative of biologically 
relevant communities from a particular location in the intestine, including the colon 
(Dubos et al., 1967; Savage, 1987).  
In the present study, administration of non-therapeutic concentrations of model 
AGP (i.e. AS700 for cattle; CTC for mice) did not substantially affect the intestinal 
microbiota of mice and cattle. However, definitive conclusions on the effects of AGP on 
the intestinal microbiota were obscured by substantial variability among individuals. 
Although all mice (i.e. a mammalian AGP model) were from the same genetic 
background, and cattle as well as mice were subjected to similar experimental conditions 
(i.e. diet, handling, environment), considerable inter-animal variability in the composition 
of the intestinal microbiota was encountered. 
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6.3 General conclusions 
A primary objective of the current research was to determine if AGP would affect 
immune responses of the mice to C. rodentium, and if it would induce a significant shift 
in composition of the intestinal microbiota of cattle and mice. Although administration of 
CTC modulated murine immune responses to C. rodentium, it was not possible to 
definitely determine if this effect resulted from a direct action of AGP, shifts in intestinal 
microbiota composition, or both. Overall, it was concluded that CTC did not cause 
consistent modifications in the microbial communities in either cattle or mice. This 
conclusion is consistent with the findings from other studies. For example, a commonly 
used AGP did not induce substantial changes in abundance of selected bacterial 
phylogenetic groups of the cecum of chickens (Wise and Siragusa, 2007). Similarly, oral 
administration of non-therapeutic concentrations of virginiamicin and tylosin to 
intensively raised pigs did not affect the composition of the fecal microbiota or fecal 
community resistance to macrolide-lincosamide-streptogramin B (Kalmokoff et al., 
2010). These findings are consistent with the immunomodulation hypothesis of AGP 
action, which would explain the consistency of growth promoting effects observed in 
animals with highly dissimilar microbiota compositions, as well as in animals 
administered AGP with distinct spectra of antimicrobial action. Furthermore, it is 
unlikely that AGP would substantially reduce the microbial load without disrupting 
colonization resistance, which comprises a complex network of interactions between the 
microbiota and the intestinal mucosa, and is thought to inhibit colonization by pathogens 
(Stecher and Hardt, 2008). Nevertheless, findings of this research do not preclude the 
possibility that AGP administration could exert shifts in microbial composition as a result 
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of altered immune responses induced directly by AGP. Further evidence that AGP exerts 
an effect on the immune system of the host is supported by a study in which AGP 
administration ameliorated weight loss in chickens maintained in an unsanitary 
environment, whereas no evident growth promoting effect was observed in those 
maintained in a clean environment (Roura et al., 1992). Therefore, administration of AGP 
might reduce immune-mediated stress and enable more energy to be used towards growth 
development (in lieu of the acute-phase response). This warrants examination. 
 
6.4 Restricted use of antimicrobial growth promoters 
It is well established that AGP enhance growth of animals maintained in unsanitary 
environments (Roura et al., 1992); therefore, some producers have come to rely on AGP 
administration to compensate for poor management practices (HC, 2002). Thus, a ban on 
AGP should stimulate improvements in management and husbandry practices that reduce 
stress and promote animal health. However, there are some forms of stress that cannot be 
entirely prevented with management practices (e.g. stress due to weaning). For instance, 
the ban on AGP administration in Denmark corresponded with increased mortality in 
weaned piglets (Jensen and Hayes, 2003).  
 
6.5 Alternatives to antimicrobial growth promoters 
The emergence of AMR, and restrictions on the use of AGP have become a driving 
force to identify alternatives to AGP. Favorable alternatives to AGP are regarded as 
natural growth promoters, or non-antibiotic growth promoters (NGP), and include: 
probiotics (Estienne et al., 2005; Opalinski et al., 2007), prebiotics (Chee et al., 2010), 
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oils, herbal extracts, and organic acids/salts (Huyghebaert et al.). To date, research with 
NGP has been predominantly observational, and has not focused on elucidation of 
mechanisms. Unfortunately, since many NGP exhibit variable effects on animal growth 
performance, has promulgated the conclusion that NGP will not be as efficacious as AGP 
(Huyghebaert et al.). However, the use of multiple NGP in concert may be promising. 
The application of efficacious alternatives to AGP will be greatly facilitated if the 
mechanisms of action of AGP and NGP are elucidated. In this approach, the search for 
efficacious alternatives may be targeted (i.e. with host and/or microbiota effects that 
mimic AGP).  
Probiotics are defined as ‘‘live microorganisms which, when consumed in adequate 
amounts as part of food, confer a health benefit on the host” (WHO, 2001). Lactic acid 
bacteria and its components modulate the immune system, and in many cases enhance the 
immune response. In that regard, several probiotic effects are mediated through immune 
regulation, particularly through balance control of pro-inflammatory and anti-
inflammatory cytokines (Yasui et al., 1999). Moreover, probiotics have distinct 
regulatory effects on healthy persons, as well as those with inflammatory diseases 
(Isolauri et al., 2001), suggesting that the immunomodulatory effects of probiotics may 
depend on the immunologic state of the host. For example, probiotics enhanced growth in 
weaned pigs, but did not alter the growth performance of pre-weaned pigs (Estienne et 
al., 2005). 
A prebiotic is “a selectively fermented ingredient that allows specific changes, both 
in the composition and/or activity in the gastrointestinal microflora that confers benefits 
upon host well-being and health” (Roberfroid, 2007). Prebiotics are administered orally, 
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usually to monogastric animals, and are regarded as better energy substrates for 
“favorable bacteria” (e.g. bifidobacteria and lactobacilli), allowing these bacterial species 
to proliferate at the expense of less beneficial species, such as Clostridium spp. and 
Salmonella spp. (Yang et al., 2009). Currently, not all dietary carbohydrates are 
considered prebiotics (Roberfroid, 2000). Many types of oligosaccharides (i.e. commonly 
referred to as a prebiotic ingredient) have been used as feed additives to promote animal 
growth, including: inulin, fructo-oligosaccharides (FOS) of cereals, trans-galacto-
oligosaccharides of milk products, and mannan-oligosaccharides of yeast cell walls 
(Falcão-e-Cunha et al., 2007). Similar to probiotics, the effects of oligosaccharides on 
animal performance lack consistency. For example, administration of 4 g kg-1 of FOS to 
the basal diet increased average daily weight gain of broilers, whereas administration of 8 
g kg-1 FOS to the basal diet did not have any effect (Xu et al., 2003). These 
inconsistencies in the efficacy of oligosaccharides on animal growth performance may be 
related to the combined effects of their nutritional impact and the components of the diet, 
as well as the stimulation of growth and metabolic activities of various bacterial species 
(Maczulak et al., 1993), including those which are potentially harmful. The combination 
of prebiotics and probiotics (i.e. synbiotics) may have a synergistic effect, since this 
combination can improve survival of the probiotic organisms, by providing specific 
substrates for fermentation (Yang et al., 2009). 
Organic acids have been shown to increase animal growth performance through 
antimicrobial and anti-inflammatory effects. Short-chain fatty acids, such as butyric acid, 
seem to be an important energy source for intestinal epithelial cells and have stimulated 
epithelial cell proliferation and differentiation (Dalmasso et al., 2008). Furthermore, 
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supplementation of feeds with butyric acid decreased the incidence of necrotic enteritis 
caused by C. perfringens in broilers (Timbermont et al., 2010), as well as strengthened 
the intestinal mucosal barrier by increasing production of antimicrobial peptides in 
mucus, and by stimulating expression of tight junction proteins (Peng et al., 2007). 
Spices, herbs, essential oils, and their extracts possess anti-oxidant, antimicrobial, 
anti-rheumatic, nephroprotective, antimutagenic, anticancer, gastroprotective, 
hepatoprotective, lipid-lowering, anti-ulcer, and anti-inflammatory activities (Mofleh, 
2010), and are frequently suggested as potential alternatives to AGP. Bio-active 
components of plants are mostly secondary metabolites, and include terpenoids, 
phenolics (tannins), glycosides and alkaloids (Huyghebaert et al.). In one study, clove 
and oregano fed together provided growth performance close to that of pigs fed AGP 
(Costa et al., 2007), which makes the use of herbal extracts a promising alternative to 
AGP. The challenge is to assess the potential for synergy among various herbal extracts, 
and to identify and quantify the multitude of actions and claims improving feed 
utilization, animal physiology and health status when testing herbal extracts as 
alternatives to AGP (Huyghebaert et al.). 
 
6.6 Future research 
Further investigations should assess specific mechanisms of immunomodulation by 
AMA that are commonly used as AGP (Table 1.1). The use of in vitro models of 
intestinal epithelial barrier (Le Ferrec et al., 2001) are expected to provide in depth 
analysis of bioavailability and absorption of various types of AMA, and of specific 
metabolic pathways that may be regulated by AMA at the mucosal level. The great 
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advantages of in vitro models include the possibility of undertaking large-scale 
experiments, and the control of variables and environmental conditions, which will assist 
in elucidating specific biochemical and physiological pathways. Organotypic models (e.g.  
intestinal cell lines) enable assessments of specific cellular processes (Spottl et al., 2006). 
In comparison to intestinal cell lines, isolated and perfused intestinal segments offer the 
advantage of working with an intact organ, where physiological interactions among cells 
and the intracellular matrices are preserved (Le Ferrec et al., 2001). The major limitation 
of perfused intestinal segments is the short duration of the experiments, given the 
difficulty of maintaining tissue viability for an extended interval.  
Regarding interactions between AMA and the immune system, macrolides, 
quinolones, and tetracyclines are the most investigated AMA to date (Rubin and 
Tamaoki, 2005). It has been reported that stimulation with TNF- and IFN- has 
increased the accumulation of azythromycin in macrophages in vitro (Bermudez et al., 
1991). The uptake of erythromycin, chloramphenicol, rifampin, tetracycline, and 
lincomycin by alveolar macrophages has also been documented (Hand et al., 1984). The 
mechanism of AMA accumulation in immune cells is unclear, and is thought to be a 
protein-mediated process (Rubin and Tamaoki, 2005). Immunomodulatory effects of 
AMA on phagocytic functions have been widely studied (Labro, 2000). Macrolides 
prevented leukocyte adhesion, reduced macrophage and leukocyte accumulation, 
stimulated macrophage chemotaxis, induced phagocytosis, ameliorated neutrophil-
induced epithelial damage, and inhibited oxidative burst of neutrophils in vitro (Labro, 
2000; Rubin and Tamaoki, 2005). Regarding inflammatory responses, macrolides and 
quinolones reduced the mRNA expression of proinflammatory cytokines, including TNF-
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, IL-1, and IFN-, in vivo and in vitro, in a concentration-dependent manner (Rubin 
and Tamaoki, 2005). To my knowledge, the assessment of immunomodulatory effects of 
AMA on enterocytes has not been performed. Furthermore, the majority of studies 
regarding immunomodulatory properties of AMA were performed with therapeutic 
concentrations (Labro, 2000). Therefore, it would be prudent to conduct assessments of 
the immunomodulatory effects of AMA on intestinal cell lines in a dose-dependent 
manner, including the use of non-therapeutic concentrations of AMA.  
The use of in vitro and in situ models will certainly contribute to assessing specific 
immunomodulatory effects by AGP. Nevertheless, mechanisms of AGP action should 
also be studied within the dynamic interactions of the mammalian intestine. The intestinal 
“loop” model, in which an intestinal segment is surgically separated and subdivided in 
“loops”, provides a valuable tool for in vivo physiological interactions, and has been used 
in small ruminants to assess mucosal immune responses (Gerdts et al., 2001), as well as 
to assess systemic immune responses, e.g. lymphocyte trafficking to the intestine 
(Meurens et al., 2009). In comparison to the in situ model, the intestinal “loop” model 
provides the advantage of working with an individualized compartment of the intestine, 
which has normal physiology for an extended interval. The introduction of catheters to 
the intestinal “loop” model (Uwiera et al., 2009) should enable the assessment of long-
term immunological responses to AGP in a ruminant model, given the possibility of 
introducing multiple treatments over an extended interval.  
The use of in vivo models for the study of interactions in the intestine is extremely 
valuable; however, the complexity of the indigenous microbiota, and substantial inter-
animal variability in microbiota composition may hinder assessments of direct effects of 
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AGP on the immune system of the host. In this regard, the use of germ-free mice may 
beneficial for ascertaining the effects of non-therapeutic AGP on host responses by 
removing inter-animal variability with respect to the intestinal microbiota. However, due 
to the lack of interaction with microorganisms, germ-free mice have profound alterations 
in the immune system, intestinal morphology, absorptive function, electrolyte handling, 
bile metabolism, motility, and enteroendocrine functions (Smith et al., 2007), which 
would alter the effects of AGP on the host. It is noteworthy that establishment of Altered 
Schaedler Flora (ASF), consisting of eight murine bacterial species, conferred normal 
physiological functions within the gut and provide a gnotobiotic model to examine the 
host-microbiota interaction (Sarma-Rupavtarm et al., 2004). Thus, the use of ASF mice 
may be advantageous to elucidate the complex interactions among the host, AGP, and 
microbiota.  
As described here, an inflammation inciter is considered necessary to study 
immunomodulatory effects of AGP in an in vivo model. In the current study, C. 
rodentium was effective for assessing immunomodulatory effects of AGP in a mouse 
model. Evaluating immunomodulatory effects by AGP through various inflammatory 
pathways, such as oxidative stress, is also warranted to elucidate mechanisms of action of 
AGP.  
One of the murine responses to C. rodentium infection is the up-regulation of 
inducible nitric oxide synthases (iNOS), which are central to innate immunity and 
contribute to host defenses (Vallance et al., 2002). Nitric oxide plays a critical role in 
several physiological processes in the gastrointestinal tract, such as motility, secretion, 
digestion, absorption and elimination (Dijkstra et al., 2004). There are two constitutively 
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expressed NOS, that produce small amounts of NO: neuronal NOS (nNOS – type I) and 
endothelial NOS (eNOS – type III; Dijkstra et al., 2004). The third, inducible form (iNOS 
– type II), produces large amounts of NO and its induction occurs in states of 
inflammation and immune activation, being regulated by nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-B; Dijkstra et al., 2004). High concentrations of 
NO may act in a negative feedback to block prolonged activation of NF-B, thereby 
limiting chronic inflammation (Dijkstra et al., 2004; Korhonen et al., 2001; Meng et al., 
1998). There is a combination of cytokines and LPS to activate iNOS, and NO seems to 
have antimicrobial effects, serving as a microbial killing mechanism in activated 
macrophages (Korhonen et al., 2001).  
Alternative murine enteric inflammation models may also be used to assess 
mucosal immune responses that are potentially modulated by AGP. Disruption of the 
murine intestinal epithelial barrier function and colitis may be experimentally induced 
with the use of chemical agents, such as 2,4,6-trinitro benzene sulfonic acid (TNBS), 
oxazolone, and dextran sulfate sodium (DSS; Wirtz et al., 2007). Colitis induced by DSS 
is thought to be mediated by IL-6, IL-12, IL-17, and TNF- (Lorenz et al., 2005). Model 
pathogens that cause murine colitis, such as Salmonella typhimurium (Hapfelmeier and 
Hardt, 2005), and Listeria monocytogenes (Cossart and Toledoarana, 2008; Lecuit et al., 
2007) may also be useful to assess alternative pathways of intestinal inflammation.  
To assess the growth promoting effects of AGP, animal catabolism at the muscular 
level (i.e. protein turnover), and systemic immunologic stress response should be 
measured. Corticosterone has been described as a mediator of the immunologic stress 
response (Klasing et al., 1987). Protein radioactivity was effective to determine rates of 
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protein degradation and synthesis (Costelli et al., 1993). Studies with protein metabolism 
assessments may be conducted at the whole-body level, or at the regional level (i.e. 
specific muscles), and require the use of steady-state isotopic techniques, which are 
logistically challenging (Fouillet et al., 2002).  
 
6.7 Final conclusions 
The research conducted here provides valuable new information regarding immune 
responses that were modulated by the administration of one AGP as a model; this will 
provide a basis for future studies regarding this alternate mechanism of action. It is 
noteworthy that alternatives to AGP known to impart effects on the microbiota 
composition, as well as on components of the immune system, do not exert growth 
promotion equivalent to that exerted by AGP. A possible explanation for this is that 
neither the microbiota, nor the immune system, are independently involved in the effects 
of AGP, but rather an interaction of these two critical aspects contribute to the most 
favorable growth effects. Therefore, future research should focus on unraveling the 
mechanisms of action of AGP, and on applying this knowledge to identify alternatives 
that provide comparable growth-promoting effects to those exerted by AGP. To enable 
the identification of suitable alternatives to AGP, further investigations should include 
not only assessments on intestinal microbiota, but on host effects induced by AGP, in 
comparison with synergistic effects in the host induced by NGP. 
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APPENDICES 
 
 
APPENDIX ONE. SAS program3 for identification of T-RFs in T-RFLP analyses 
 
******  Macro variables that can be set by the user  ****************************; 
%let in_file = .txt;   * Specify the input file name; 
 
%let out_file = .html;       * Specify the output file name; 
 
%let var = ;            * Specify the variable to be used to find peaks; 
                                 * The choices are peak_height or peak_area; 
 
%let var_mult = ;             * Defines peaks - peaks are above VAR_MULT * 
VARIABILITY; 
 
%let adjust_for_mean = ;       * Used to control how the variability is calculated. 
                                   Set to YES if you want to adjust for the mean (YES/NO); 
 
***  Use these to control what is printed (YES / NO) 
*************************************; 
%let p_all_data   = YES;         * Print all the data with peaks identified; 
%let p_only_peaks = YES;         * Print the results with ID values in columns; 
 
***********************************************************************; 
********   Macro used for printing  ********************; 
* This macro is used to control the printing; 
 
%macro print(title= , data= , print= ); 
  %if %upcase(&print) eq YES %then %do; 
    title "&title"; 
 
    proc print data=&data noobs uniform; 
    run; 
  %end; 
%mend; 
 
********************************************************; 
options nocenter; 
 
ods html style=minimal 
         body = "&out_file"; 
 
*****   Read the data from an external file     **************************; 
data file1; 
                                                 
3 Toby Entz (AAFC LRC) designed the present SAS program. 
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  infile "&in_file" expandtabs truncover firstobs=4; 
 
  peak = 0; 
 
  input id $ rep peak_num plus_minus frag_size peak_height peak_area; 
run; 
 
***********************************************************************; 
* Create a numeric index for the id values so they can be proccessed  
  in an IML matrix; 
 
proc sort data=file1; 
  by rep id; 
run; 
 
data file1; 
  set file1 end=eof; 
  by rep id; 
 
  retain index 0; 
 
  if first.id then index = index + 1; 
 
  if &var ge 0 then  
    sq_var = &var * &var; 
 
  if eof then 
    call symput('max_index', index); 
run; 
 
***********************************************************************; 
* Find the peaks based on the variance.  PEAK is set to 1 for a peak and  
  to 0 otherwise; 
 
proc iml; 
   use file1; 
     read all var (rep index &var sq_var peak peak_num) into in_data; 
   
   rows = nrow(in_data); 
   index_end = 0; 
 
   do index = 1 to &max_index; 
 
     flag = 1; 
     index_start = index_end + 1;      
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     * See where the current ID starts and ends; 
 
     do i = index_start to rows; 
       if in_data[i, 2] = index then 
         index_end = index_end + 1; 
     end; 
 
     do while (flag = 1); 
       flag = 0; 
       sum_sq = 0; 
       sum = 0; 
       count = 0; 
 
       * Calculate the sum of squares and the cutoff value using 
         only values that are not identified as peaks; 
 
       do i = index_start to index_end; 
         if in_data[i, 5] = 0 & in_data[i, 3] > 0 then do; 
           sum_sq = sum_sq + in_data[i, 4]; 
 
           if "%upcase(&adjust_for_mean)" = "YES" then 
             sum = sum + in_data[i, 3]; 
 
           count = count + 1; 
         end; 
        end; 
 
       cut_off = &var_mult * (sqrt((sum_sq - (sum*sum / count)) / (count - 1))); 
 
       * Set PEAK to 1 from 0 if the cutoff is exceeded; 
        
       do i = index_start to index_end; 
         if in_data[i,3] > cut_off & in_data[i, 5] = 0 then do; 
           in_data[i,5] = 1; 
           flag = 1; 
         end; 
        end; 
      end; 
  end; 
 
  create file2 from in_data [COLNAME=(rep index &var sq_var peak peak_num)]; 
  append from in_data; 
run; 
 
***********************************************************************; 
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*  Combine the peak identification information with the original data set ***; 
 
proc sort data=file1; 
  by rep index peak_num; 
run; 
 
proc sort data=file2; 
  by rep index peak_num; 
run; 
 
data file1 (keep = rep id peak peak_num frag_size peak_height peak_area ); 
  merge file1 (drop = peak) 
        file2; 
 
  by rep index peak_num; 
run; 
 
***********************************************************************; 
proc sort data=file1; 
  by id peak_num rep; 
run; 
 
%print(title=All the used data: PEAK=1 for identified peaks -  
             %upcase(&var) used to identify peaks.  
             Peak defining muliplyer = &var_mult, 
       data=file1, print=&p_all_data) 
 
**********************************************************************; 
* Compare the 2 reps and set PEAK to 1 if both are peaks; 
 
data file2 (keep = id peak_num peak1) 
     file3 (keep = id peak_num peak2); 
  set file1; 
 
  if rep eq 1 then do; 
    peak1   = peak; 
    output file2; 
  end; 
  else if rep eq 2 then do; 
    peak2   = peak; 
    output file3; 
  end; 
run; 
 
proc sort data=file2; 
  by id peak_num; 
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run; 
proc sort data=file3; 
  by id peak_num; 
run; 
 
data file1 (keep = id peak_num peak); 
  merge file2 file3; 
  
  by id peak_num; 
 
  if (peak1 eq peak2) and peak1 eq 1 then 
    peak = 1; 
  else  
    peak = 0; 
run; 
 
***********************************************************************; 
***  Transpose the data so that the ID form the columns  ********************; 
 
proc sort data=file1; 
  by peak_num; 
run; 
 
proc transpose data=file1 out=file100; 
  by peak_num; 
 
  id id; 
 
  var peak; 
run; 
data file100; 
  set file100; 
 
  drop _name_; 
run; 
 
%print(title= Peak = 1  No peak = 0 - %upcase(&var) used to identify peaks.   
             Peak defining muliplyer = &var_mult, 
       data=file100, print=&p_only_peaks); 
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APPENDIX TWO. Agar diffusion method. Inhibition zones observed around wells on a 
TSA dish, using S. aureus strain ATCC 29213 as the indicator organism. Each well 
contained known concentrations of CTC: (A) 2 µg mL-1 CTC solution; (B) 3 µg mL-1 
CTC solution. 
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APPENDIX THREE. Growth curves of wild-type (A) and tetO-transformed (B) C. 
rodentium in LB broth with and without tetracycline (50 µg mL -1), respectively.  
 
 
 
 
